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Protein-protein interactions are crucial for the formation of complexes involved 
in the regulation of transcription. Interactions of the human linker histone hH1 
with the other core histone proteins, hH2A, hH2B, hH3 and hH4 have been 
analyzed inside human HT1080HPRT- cells with the help of the two-component 
split-ubiquitin system. The linker histone regulates the condensation and 
decondensation of chromatin by binding to the nucleosomes externally. 
However, the position and the orientation of the linker histone with respect to 
the nucleosomal histone proteins are still not clear. Studying the interaction of 
the linker histone with core histone proteins should yield interesting insights 
about its exact location. I have found human histone hH1 to specifically interact 
with the human core histone proteins hH3 and hH4. These interactions have 
been verified by co-immunoprecipitation in HEK293 cells. Molecular modeling 
has helped us to visualize the contact between the linker histone hH1 and hH3 
and hH4 in the context of the nucleosome. The split-ubiquitin system is 
uniquely suited for screening of transcription factor-binding proteins. It does not 
rely on transcriptional readouts for detecting protein-protein interactions unlike 
the mammalian two-hybrid system. Moreover, it allows for host cell-specific 
post-translational modifications to occur for proteins interacting with histone H1, 
which has been chosen as bait in the control and screening experiments 
mentioned below.  
 A high throughput method for screening of interacting partners for human linker 
histone inside human cells has also been developed. I have adapted this 
system in human HT1080HPRT- cells using Adeno-Associated Viral particles 
for delivery and expression of a human cDNA library. Dicistronic expression of 
GFP from the same plasmid carrying human histones and Prothymosin as a 
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positive control was used to isolate transduced cells with the help of FACS. 
Cells with positively interacting bait and prey fusions were selected in medium 
containing 6-TG and zeocin based upon conditional degradation of the Gpt2 
(guanine phosphoribosyl transferase). The integrated viral DNA can be 
recovered from the cells by genomic DNA extraction and PCR. Sequencing of 
the purified PCR product reveals the identity of the interacting partner. This 
system has a high hit rate as well as a low background for yielding false 
positives.  This system could be used to screen cDNA libraries in the future. 
Identification of linker histone-interacting proteins might yield interesting 






































1.1. Aims and Objectives 
 
Protein-protein interactions control cellular organization and dynamics in 
diverse biological processes including transcription. Studying transcriptional 
initiation and the interplay between the transcription machinery and chromatin 
proteins is crucial in our understanding of gene expression during various 
stages of development and differentiation of multicellular organisms. The split-
ubiquitin system was originally devised as a protein interaction assay for yeast 
by Johnsson et al. in 1994. It has been adapted for human cells by Rojo-
Niersbach et al. in 2000. This unique in vivo protein interaction assay, 
discussed in detail in Section 1.4, offers a novel method to identify interaction 
partners for proteins inside living human cells.   
The first aim of my Masters project is the characterization of protein-protein 
interactions between the linker histone H1, an important player in governing 
chromatin structure (Section 1.2.6 and Chapter three), and the core histones 
H2A, H2B, H3 and H4 using the split-ubiquitin system. The main objective of 
this analysis is to demonstrate the feasibility of the split-ubiquitin system to 
detect interactions between human proteins inside human cells and also to 
provide answers regarding the nature of the protein interactions between the 
linker histone and the core nucleosome. 
The second aim of this project is to design a high throughput method based on 
the split-ubiquitin system for screening of interacting partners inside human 
cells using the linker histone as a bait protein. This novel interaction screening 
method could potentially be used with any of the numerous human cellular 
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proteins as baits. It is indeed a challenge to identify the entire set of protein 
interactions for human proteins due to the sheer variety of post-translational 
modifications, alternative splicing, sequence polymorphisms and the complex 
array of cell types with differentially expressed variants for each protein. 
 
1.2 Gene Expression in Humans: Mechanisms of Transcription 
 
Humans have a predicted number of 26,588 genes (Venter et al, 2001). 
However in a given cell population only 1-2% of the genes might actually be 
expressed. The first step in gene expression is the process of transcription 
catalyzed by RNA polymerase. Differences in gene expression govern different 
states of differentiation, homeostasis, growth and cell function. All these 
functions are achieved by direct transcriptional control of gene expression.   
It is envisaged that epigenetics, imposed at the level of DNA-packaging 
proteins (histones) might be a critical feature of information storage and 
retrieval during embryonic development and differentiation. According to 
Jenuwein and Allis, 2001; chromatin structure plays an important role in gene 
expression. Histone protein modifications allow regulatable contacts with the 
underlying DNA. Many signaling pathways in turn converge on histones. The 
enzymes catalyzing their modifications are highly specific for particular amino 
acid positions, thereby extending the information content of the genome past 
the DNA code.  It is proposed that the formation of distinct higher order 
structures such as euchromatin and heterochromatin domains is largely 
dependent on the local concentration and combination of modified histones 






1.2.1. Transcriptional Regulatory DNA Sequences 
 
The basic substrate of the transcription machinery consists of the chromatin 
template. The smallest unit of chromatin is the nucleosome, which comprises of 
146 base pairs of DNA wrapped around a histone protein octamer complex 
(Kornberg, 1977). This fundamental unit of organization has been preserved in 
all eukaryotes. The nucleosome provides the first level of organization giving a 
packaging ratio of ~6 to the DNA (Lewin, Genes VIII, Pearson Prentice Hall, 
2004). The second level of organization is the coiling of nucleosomes into 
helical arrays to constitute a 30nm fiber that is found in both interphase 
chromatin and mitotic chromosomes and renders a packaging ratio of ~40. The 
final packaging ratio is determined by the folding of the 30nm particles upon 
themselves to give an overall packaging ratio of ~1,000 in euchromatin and 
10,000 for heterochromatin in mitotic chromosomes (See Figure 1.1). 
Heterochromatin regions generally have a packaging ratio of 10,000 both 
during interphase and mitosis.  
Transcription requires unwinding of chromatin for relevant enzyme complexes 
and transcription factors to gain access to the DNA. RNA is transcribed from 
the DNA template by the RNA polymerase when it binds to a special region on 
the DNA called the “promoter” lying at the start of every gene. The promoter 
consists of an AT rich sequence, the TATA Box, and sequences bound by 
transcriptional regulators (See Figure 1.2). The promoter surrounds the first 
base pair that is transcribed called the “transcription start site” from which RNA 
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polymerase moves along the template synthesizing RNA until it reaches the 
terminator sequence. This sequence, from the promoter to the terminator, 
comprises the transcriptional unit.  
 In a recent study, 174 new regulatory motifs were identified for humans (Xie et 
al., 2005). Using gene expression data from 75 human tissues, significant 
enrichment in one or more tissues was seen for 59 of the 69 (86%) known 
motifs and 53 of the 105 (50%) new motifs.  
The TATA Box is the binding site for the TATA-binding protein (TBP). In some 
genes, the transcription initiation site consists of the initiator element (Inr) 
defined as an element encompassing the transcription start site that binds 
regulatory factors.  
Eukaryotes also contain certain regulatory sequences called Upstream 
Activating Sequences (UASs) which are bound by activators. Also present are 
enhancers which can reside thousands of base pairs upstream of the promoter 
elements. Transcriptional enhancers integrate positional and temporal 
information to regulate the complex expression of developmentally controlled 
genes. Current models suggest that enhancers act as computational devices, 
receiving multiple inputs from activators and repressors and resolving them into 
a single positive or negative signal that is transmitted to the basal transcription 
machinery (Kulkarni and Arnosti, 2003). DNA elements can be also bound by 
repressor proteins. These are called Upstream Repressing Sequences or 
URSs. Silencers are defined as sequence elements that can repress promoter 





Figure 1.1. Steps in chromatin assembly (Adapted from Ridgway and 
Almouzni, 2001) 
The basic nucleosome is formed by the assembly of 146bp of DNA wrapped 
around a histone octamer complex. Nucleosomal arrays are further folded into 








Figure 1.2.  Promoter architecture in yeast and mammals. (Reprinted from 
Molecular Cell Biology by Harvey Lodish et al. © 1986, 1990, 1995, 2000 by 
W. H. Freeman and Company. Used with permission) 
 Promoter elements of a typical mammalian gene and a S. cerevisiae gene 
have been described. These contain the transcription start site, the TATA box, 
as well as certain upstream activating sequences (in yeast) and promoter 
proximal elements (in mammalian genes). Enhancers can lie hundreds or 
thousands of bases upstream of the basic promoter element. The mammalian 

































orientation and position dependent fashion. For example CpG islands have 
been implicated in silencing by methylation (Antequera and Bird, 1998). 
 
1.2.2. Gene Specific Activation and Repression 
 
Activation of genes is achieved by the binding of transcriptional activators to 
upstream activating sequences. Activators consist of two domains: one is the 
DNA binding domain and the other is activating domain which stimulates the 
activity of transcriptional apparatus. Transcriptional activators can recruit 
chromatin modifying complexes such as the Swi/Snf and SAGA (PCAF) to 
promoters (Blanco et al., 1998). The human counterparts of the chromatin 
modifying complexes in yeast hBAF (Swi/Snf in yeast) and hPBAF (Rsc in 
yeast) have also been described recently (Mohrmann et al., 2005). These 
chromatin remodeling factors either utilize energy by ATP hydrolysis (Swi/Snf) 
to loosen the contacts between histones proteins and DNA or they acetylate 
histones (SAGA), thereby activating genes (See Figure 1.3). 
The transcriptional activators can recruit much of the transcriptional apparatus 
including RNA polymerase II, general transcription factors in a single or multiple 
steps (Greenblatt et al., 1997).  
Repressors are equally important and can be classified into general repressors 
or gene specific repressors. Many general repressors function via interactions 
with TBP. Mot1, for example, represses transcription by binding to TBP and 
causing its dissociation in an ATP-dependent manner (Auble et al., 1997). 




                                                               
Figure 1.3. Regulating nucleosomal mobility. (Reprinted from Nature 
Structural and Molecular Biology, Cosgrove et al., 2004, used with 
permission) 
a) Chromatin is regulated by factors that control the equilibrium between 
nucleosomes with low versus high mobility. Proposed intermediates are 
shown on the pathway of transcriptional activation and repression, 
catalyzed by the concerted action of ATP-dependent nucleosome-
remodeling factors (ADNR) and covalent histone-modifying enzymes. 
Activation can be achieved by histone modifications that weaken 
histone-DNA contacts, such as acetylation by HATs, resulting in 
increased nucleosome mobility. Repression is achieved by histone 
modifications that restore histone DNA contacts, such as deacetylation 
by HDACs, resulting in decreased nucleosome mobility. (b) Uncoupling 
regulation of nucleosome mobility by GCN5 or SWI/SNF knockouts 
blocks gene expression by preventing the switch from nucleosomes with 
low mobility to nucleosomes with high mobility. Mutation of histone-DNA 
contacts (SIN mutations) relieves repression in gcn5 and swi/snf strains 
by weakening histone-DNA contacts, resulting in increased nucleosome 
mobility and access to DNA. Mutations that prevent restoration of 
histone-DNA contacts (Lrs mutations) uncouple control of nucleosome 
mobility by deacetylation, preventing the switch from nucleosomes with 
high mobility to low mobility, resulting in the loss of gene silencing.  
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proteins or by binding to co-repressors like N-cor, SMRT, Rb (Ayer et al., 
1999). Deacetylase activity can be linked to methylated DNA by MeCP2 which 
binds to methyl-CpG within the chromatin causing gene silencing (Bird et al., 
2002; Nan et al., 1998; Jones et al., 1998). 
 
1.2.3 RNA Polymerase II and the Basic Transcriptional Apparatus 
 
The assembled initiation apparatus consists of 12 subunits of RNA polymerase 
II core enzyme, general transcription factors and one or more complexes called 
co-activators or mediators (See Figure 1.4). Genes for the 12 human RNA 
polymerase II subunits have been described and they show a lot of homology 
with their yeast counterparts. Its various subunits have diverse functions like 
start site selection, elongation and interaction with activators.  The largest 
subunit of RNA Polymerase II contains a unique carboxyl-terminal repeat 
domain (CTD) that consists of tandem repeats of consensus heptapeptide 
sequence (Tyr-Ser-Pro-Thr-Ser-Pro-Ser) (Corden et al., 1990). There are 52 
such heptapeptide sequences in humans. 
The phosphorylation state of CTD determines various stages of transcription. 
RNA polymerase II is recruited to the initiation complex in the unphosphorylated 
state whereas during elongation it becomes heavily phosphorylated (Dahmus et 
al., 1996). CTD can be phosphorylated by many kinases like TFIIH (Feaver et 
al., 1991), Srb10/Cdk8 kinase and Kin28 (Holstege et al., 1998). Fcp1 is a CTD 
phosphatase which binds to the general transcription factor TFIIF suggesting its 





Figure 1.4. (Reprinted with permission from the Annual Review of 
Genetics, Volume 34 © 2000 by Annual Reviews www.annualreviews.org)  












A pre-initiation complex consisting of the General Transcription Factors (GTFs) 
and RNA polymerase II can assemble in a stepwise manner with the promoter 
elements being bound by TBP or TFII-D followed by TFIIA, TFIIB, a 
subcomplex of RNA polymerase II and TFIIF, TFIIE, and finally TFIIH 
(Buratowski 1994). 
The RNA polymerase II holoenzyme complex consists of a subset of general 
transcription factors and the Srb/Mediator complex. The mediator contains 
certain regulatory proteins of the RNA polymerase II (Hengartner et al., 1995) 
which can associate with the CTD and stimulate its phosphorylation. Certain 
human Srb/Mediator complexes (SMCC) (Gu et al., 1999) can mediate 
activation with thyroid hormone receptor.   
To produce an RNA transcript, the formation of stable transcriptional initiation 
complex must be followed by promoter clearance and processive elongation. 
This is brought about by phosphorylation of CTD (Dahmus et al., 1996). This 
process appears to involve a balance between negative and positive regulatory 
factors. 
 
1.2.4 Histones : DNA Packaging Proteins Regulating Transcription  
 
Chromatin is organized in arrays of nucleosomes (Kornberg, 1977). Two copies 
of each histone protein, H2A, H2B, H3 and H4, are assembled into an octamer 
that has 145-147 base pairs of DNA wrapped around it to form the nucleosome 
core (See Figure 1.5). The repeating nucleosome cores can be further 




Figure 1.5. Nucleosome core particle.  (Reprinted from Nature, Luger et 
al., 1997, used with permission) 
Ribbon traces for the 146-bp DNA phosphodiester backbones (brown and 
turquoise) and eight histone proteins main chains (blue: H3; green: H4; yellow: 
H2A; red: H2B. The view is down the super helix axis for the left figure and 













histone H1. The nucleosome core, linker DNA and H1 shape the DNA molecule 
both at atomic level through DNA bending and by forming higher order 
structures (Widom, 1989), which are obstacles for transcription. The 
nucleosome is the main determinant of DNA accessibility. The protein octamer 
is divided into four ‘histone-fold’ dimers defined by H3-H4 and H2A-H2B histone 
pairs (Kruger et al., 1997). The central histone-fold domains form three -
helices connected by two loops, L1 and L2.   
Histones are subject to a variety of modifications which can directly impact 
chromatin structure or can lead to recruitment of trans-acting factors that 
recognize specific modifications. There exist several modifications, e.g., 
acetylation, phosphorylation, methylation, glycosylation, sumoylation, 
biotinylation, mono-ubiquitination and poly (ADP-ribosylation) (Strahl and Allis, 
2000; Berger, 2001; Goldknopf, 1975; Kothapalli et al., 2005). These act as a 
scaffold for the recruitment of specific regulatory proteins or protein complexes 
that participate in nuclear processes including transcription, recombination, 
DNA replication and repair (Jenuwein and Allis, 2001). This has given rise to 
the “histone code” hypothesis, according to which a combination of these 
modifications may serve to establish and maintain distinct epigenetic states in 
the chromosomes (Turner, 2002; Strahl and Allis, 2000). 
In the context of transcription certain, modifications like acetylation of histones 
H3 at lysines 9 and 14 are strongly associated with active chromatin (Kurdistani 
and Grunstein, 2003). Acetylated histones can be recognized by chromatin 
associated proteins containing bromodomains (Dhalluin et al., 1999; Jacobson 






Figure 1.6.  Annotation map of known histone modifications on the 
surface of the X. laevis nucleosomal core particle. (Reprinted from Nature 
Structural and Molecular Biology, Cosgrove et al., 2004, used with 
permission) 
(a) Surface representation of the vertebrate nucleosome core particle (without 
flexible tails) viewed down the DNA super helix axis. (b) View as in a, but 
rotated 90° around the molecular dyad axis. (c) View as in (a) but rotated 90° 


















of 110 amino acids that are conserved in many chromatin-associated proteins, 
including histone acetyltransferases (HATs) such as PCAF, TAFII250, and 
certain remodeling factors like BRG-1 (Jeanmougin et al., 1997). Histone 
methylation can be associated with both active and repressed chromatin. 
Lysine can accept multiple methyl groups and, thus, can be mono-, di-, or 
trimethylated (Rice and Allis, 2001) and can recruit proteins via the 
chromodomain motif. For example H3K9 methylation is regarded as an 
epigenetic “mark” for silenced heterochromatin and 
provides a binding platform for the chromodomain protein heterochromatin-
associated protein (HP1) (Jenuwein and Allis, 2001). In contrast, it was shown 
that tri-methylation of H3 K4 is present exclusively at active genes (Santos-
Rosa et al., 2002). Hence a combination of histone modifications can specify 
alternative chromatin states.  
Recently, many previously unknown histone modifications have been mapped 
by Freitas et al., 2004, which lie in the structured globular histone core (See 
Figure 1.6), some of which are in a position to interfere with the binding of DNA 
to the nucleosomal lateral surface. Hence a new model for regulation of 
chromatin activity, which is in turn controlled by factors that regulate the 
equilibrium between nucleosomes with low mobility and those with high 
mobility, has been proposed by Cosgrove et al., 2004. Activation of genes can 
be achieved through chromatin remodeling by ATP-dependent-nucleosome-
remodeling factors (ADNR) and  histone modifications that weaken histone-
DNA contacts, such as acetylation by histone acetyl transferases (HATs) 
resulting in increased nucleosomal mobility. On the other hand, deacetylation 
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by histone deacetylases (HDACs) results in restoration of histone-DNA 
contacts, and hence repression.  
 
1.2.5 Human Histone Variants: Adding Complexity to Transcriptional 
Regulation 
 
In the human genome, several groups of histone genes have been described 
(Clark et al., 1981; Heintz et al., 1981; Zhong et al., 1983; Carozzi et al., 1984; 
Marashi et al.; Zwollo et al., 1984; Eick et al., 1989; Albig et al., 1991, 1997; 
Kardalinou et al., 1993) (See Figure 1.7.). Each class of histone proteins, 
except  
H4, consists of several subtypes encoded by different genes. In mammals, 
these genes can be sub-divided into (1) replication-dependent histone genes 
whose expression is linked to the S-phase of the cell cycle, (2) replication-
independent histone genes, which encode the so-called “replacement 
histones”, expressed at a low but constant level throughout the cell cycle and in 
nondividing cells, and (3) genes encoding tissue specific isotypes, such as H1t 
and H3t expressed in the testis (Albig and Doenecke, 1997). Eleven clusters 
comprising a total of about 60 histone genes are distributed over seven human 
chromosomes.  
Histones are one the most conserved proteins in terms of both structure and 
sequence, however in higher organisms, including humans each histone 
subtype,  is represented by multiple non-allelic primary sequence variants 
(Wolffe, 1998; Wang et al., 1997). These variants (See Figures 1.7 and 1.8) 
can contribute to distinct or unique nucleosomal architectures, which could be 
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exploited to regulate nuclear functions such as transcription, gene silencing, 
replication or recombination (Brown, 2001). The diverse functions of these 
histone variants have been highlighted in Figure 1.8 (Sarma and Reinberg, 
2005). 
H3 variants consist of H3.1, H3.2, H3.3 which are similar and CENPA, the 
centromeric histone H3 which shows a lot of sequence variability, both between 
and within the same species (Sarma and Reinberg, 2005). 
H3.3 is present at transcriptionally active loci (Ahmad and Henikoff, 2002). H3.3 
is deposited both during replication-coupled (RC) and replication-independent 
(RI) processes. During RC deposition, H3.1 is localized all over the genome, 
however during RI processes it is mainly localized in rDNA encoding regions. 
H3.1 deposition is, directed to the chromatin only during S-phase of the cell 
cycle. H3.3 also carries marks that reflect transcriptionally active genes like di-
tri methylation of H3 K4, acetylation of K9, K18, K23 and methylation of K79. It 
is present at lower levels in dividing cells compared to terminally differentiated 
cells where the level of H3.3 goes up significantly.   
CENPA, the centromeric histone H3, shares the C-terminal histone fold with 
H3, but varies extensively in the N-terminal region. However, it is the conserved 
histone fold domain that is responsible for targeting it to the centromeric regions 
(Sullivan et al., 1994).  
Four H2A variants have been identified so far: H2AX, H2AZ, macroH2A and 
H2A-bar-body-deficient (H2ABD). H2AZ is an essential gene in mammals since 
homozygous knock out of the gene in mice resulted in embryos that failed to 






Figure 1.7.  Human histone gene clusters spread over seven human 






Figure 1.8.  (Reprinted from Nature Reviews. Molecular Cell Biology, 
Sarma and Reinberg, 2005, used with permission) Known histone variants 






















been found to participate in maintenance and establishment of boundaries 
between heterochromatin and euchromatin regions (Rusche et al., 2003). 
The crystal structure of the H2AZ containing nucleosome suggests that two 
H2AZ molecules are preferred over one H2A and one H2AZ molecule (Suto et 
al., 2000).  H2AZ was shown to co-localize in pericentric heterochromatin in 
mouse development (Rangasamy et al., 2003). Also it has been shown to 
maintain HP1  to specific heterochromatin regions (Rangasamy et al., 2004). 
Hence it is postulated to a play a role in maintenance of facultative 
heterochromatin. Its incorporation stabilizes the octamer within the 
nucleosome, but prevents oligomerisation of the chromatin fibers. In yeast, 
Htz1 is selectively deposited by Swr1 complex, which is a member of the 
Swi/Snf family of chromatin remodeling factors (Mizuguchi et al., 2004). Its 
unique transcriptional role is yet to be elucidated. 
H2AX plays a role in homologous recombination (Malik and Henikoff, 2003). It 
contains an extension of the C-terminal histone domain, which includes 
conserved amino acid sequence SQ (EID) , where  represents a hydrophobic 
amino acid. Ser139 in this variant is phosphorylated in response to double 
stranded breaks produced upon by DNA damage (Rogakou et al., 1998).  
MacroH2A is a vertebrate specific histone with two domains; the N-terminal is 
similar to H2A, while the large C-terminus shows no similarity with other 
histones (Pehrson et al., 1992). This variant is found to be selectively enriched 
in the inactive X-chromosome (Costanzi et al., 1998), where it is deposited after 
localization of the inactive-X-specific transcript, Xist (Mehmoud et al., 1999). In 
undifferentiated embryonic stem cells, macroH2A is concentrated at the 
centrosomes of the nucleus, where it is tethered to the microtubules 
(Rasmussen et al., 2000) and at the onset of differentiation,  it is enriched in the 
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inactive X.  Its targeting to the inactive X is perhaps mediated by Xist RNA 
associated factors, and the exact mechanism of RNA mediated silencing is not 
yet known. 
H2ABBD is the most recently discovered H2A variant which is excluded from 
the inactive mammalian X chromosome. It is associated with acetylated lysine 
12 at H4, which indicates that it plays a role in active euchromatin regions 
(Chadwick et al., 2001). Structural studies have revealed that nucleosomes 
containing H2ABBD have a more open configuration (Gautier et al., 2004 and 
Bao et al., 2004). 
 
1.2.6 Linker Histone: Forming Higher Order Structure and Fine Tuning   
Chromatin Dynamics 
 
As shown earlier in Figure 1.1, nucleosomes are further folded into higher order 
30nm fibers by the action of the linker histone H1 which binds to each 
nucleosome forming a structure termed as the chromatosome. This higher 
order chromatin structure plays a key role in determining the transcriptional 
status of genes.  
 There are five known isoforms of histone H1 (H1.1, H1.2, H1.3, H1.4 and H1.5) 
as well as a lesser studied H1 isoform H1.X.  Simultaneous inactivation of 
these multiple H1 subtype genes causes embryonic lethality in mice (Zhang et 
al., 1997).  These subtypes have been shown to exhibit tissue specific and cell-
cycle dependent expression patterns indicating that they indeed are important 
for regulation of gene expression (Alami et al., 2003). Linker histone variants 
specifically regulate chromatin dynamics during embryonic development in 
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Xenopus, indicating unique functions of these variants (Saeki et al., 2005). 
Recently, a number of phosphorylation sites on histone H1 have been identified 
by mass spectrometry (Cosgrove et al., 2004) raising the possibility of 
extension of histone-code to the linker histone H1 lying outside the core group 
of histones.   
Details regarding the transcriptional mechanisms of the linker histone will be 
discussed in Chapter three. 
 
1.3 Protein–Protein Interactions and Transcriptional Networks 
 
Transcription factors often act in multimeric complexes. These complexes play 
crucial roles in regulating the dynamics of activation and silencing of genes at 
the level of the chromatin. Identifying protein complexes and the way they 
share components is essential for understanding their function. One step 
forward in doing so is by building protein-interaction networks, which are 
classically represented by graphs (See Figure 1.9) with proteins as nodes and 
physical interactions represented by edges connecting the nodes (Gagneur et 
al., 2004). Systematic analysis of protein-protein interaction networks has 
already been accomplished for Saccharomyces cerevisiae (Uetz et al., 2000; 
Ho et al., 2002; Tong et al., 2004) Drosophila melanogaster (Giot et al., 2003) 
and Coenorrhabditidis elegans (Li et al., 2004). Large scale interaction 
networks for these model organisms have been mainly constructed  using high-
throughput technologies like the yeast two-hybrid system (Uetz et al., 2000), 
protein-complex purification (Ho et al., 2002), double-knockouts for genetic 
interactions (Tong et al.,2004) and spotted-microarrays (Marcotte et al., 1999). 
Table 1, which highlights Interaction Coverage, by species, type of experiment 
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and volume of interaction data available in the public domain, shows that the 
number of known human protein-protein interactions is meager as compared to 
yeast, fly and the worm (Bork et al., 2004). 
Reconstruction of transcriptional networks by extrapolating interactions from 
one organism to another might be a feasible strategy to identify interacting 
partners for proteins which have been evolutionarily conserved from simpler 
organisms to humans. In fact, the first draft of the human protein-interaction 
map has been constructed (Lehner et al., 2004) from existing interaction 
databases for yeast, worm and fly. This network consists of over 70,000 
interactions that connect over one-third of all predicted human proteins, 
including 1,482 proteins of unknown function and 448 proteins encoded by 
human disease genes. However there are additional challenges in building 
human interaction networks from these model organisms. The accuracy and 
coverage of the interactions predicted depend on the quality of the original 
model organism protein and the ability to identify the human orthologs of a 
model organism protein. 
One must also take into account the sheer complexity of the human proteome. 
After the completion of the Human Genome Project, the total number of genes 
predicted for Homo sapiens is 26,588 (Venter et al, 2001). Genomic information 
does not allow the efficient prediction of all the posttranslational modifications 
(PTM) for the proteins, of which the majority of proteins are the target 
(http://tw.expasy.org/sprot/hpi/hpi_desc.html). Proteins, once synthesized on 




Figure 1.9. (Reprinted from Genome Biology, Gagneur et al., 2004, used 
with permission) Modular Nature of Protein Complexes. 
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They are cleaved (thus eliminating signal sequences, transit or pro-peptides 
and initiator methionines); many simple chemical groups can be attached to 
them (example: acetyl, methyl, phosphoryl, etc.) as well as some more complex 
molecules, such as sugars and lipids. Finally, they can be internally or 
externally cross-linked (example: disulfide bonds). More than a hundred 
different types of PTM are currently known and many more are yet to be 
discovered. The complexity due to all these modifications is compounded by 
the high level of diversity that alternative splicing can produce at the level of 
sequence. 
Thus the number of different protein molecules expressed by the human 
genome is probably closer to a million than to the hundred thousand generally 
considered by genome scientists. Another factor of complexity to take into 
account is the amount of polymorphism at the protein sequence level. While 
some of these polymorphisms are linked to disease states, most are not, yet 
have in many cases a direct or indirect effect on the activities of the proteins.  
Moreover, in Homo sapiens there is a vast array of cell types not present in the 
currently employed model organisms for genomic and proteomic studies, 
namely- yeast, worm and fly. The biological complexity of H. sapiens 
encompasses a highly developed nervous and immune system and a unique 
reproductive cycle. It can be comprehended that each cell type would indeed 
have its own protein-protein interaction network corresponding to a unique 
physiological function and comprising of cell-specific protein variants. Besides a 
complex array of cell types, there is an enormous signaling and 
communications network that occurs in the extracellular as well as the 





Table 1.1. Interaction coverage of protein-protein interactions by species.  
(Reprinted from Current Opinion in Structural Biology, 14(3),Bork, P. et 
al., Protein interaction networks from yeast to human, 292-9, 2004, with 












To summarize, a complete “human-interactome” would have to account for 
protein-protein interactions occurring not only in different cell-types and tissues, 
but also take into consideration their post-transcriptional and post-translational 
modifications in the right physiological contexts. 
Initial explorations of protein-protein interactions in the human brain (Chen et al, 
2003) using the “random yeast two-hybrid system” have classified and 
characterized all identified interactions based on Gene Ontology (GO) 
annotation of interacting loci. Functional protein-protein interactions for humans 
have also been mapped specifically for EGF (Blagoev et al., 2003) and TNF-
alpha/NF-kappa B (Andersen   et al., 2004) signal transduction pathways. 
The role of transcription and chromatin remodeling is increasingly being 
recognized in the complex diseases like cancer and numerous other imprinting 
-associated disorders like the Rett-syndrome, -thalassemia and mental 
retardation.  Building protein-protein interaction networks for the regulatory 
complexes involved in these disorders is the first step in understanding their 
molecular pathogenesis and devising possible treatments.   
 
1.3.1 Current Technologies for Screening Human Protein-Protein 
Interactions 
 
1.3.1.1. Mass Spectrometry 
Purification of biological complexes in combination with mass spectrometry is a 
powerful method to identify interacting partners.  It is a very sensitive technique 
allowing the detection and identification of 100fmol of a protein in a complex 
mixture of proteins provided that the target protein complex has been purified in 
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a reasonable quantity (Pug et al., 2001). In the first step, the bait protein is 
modified to carry an affinity tag (See Figure 1.10). Many tags have been utilized 
such as glutathione S-transferase, 6-His, calmodulin-binding peptide, and 
common epitope tags (haemagglutinin, myc, FLAG) (Phizicky et al., 2003). 
Different tags are used in combination on the same protein to allow an 
extensive purification of protein complexes by tandem affinity purification (TAP); 
first developed by Rigaut et al., 1999. In brief, this procedure involves fusion of 
the TAP tag to the target protein and introduction of the construct into the host 
cells. Cell extracts are prepared and the fusion protein along with the 
interacting partners is recovered in a two-step elution process. The TAP tag 
consists of two IgG binding Protein-A motifs and a Calmodulin Binding Protein 
(CBP) separated by a TEV protease cleavage site. In the N- and the C-terminal 
tags the order of the Protein A and CBP sites is reversed. In some species, it is 
possible to express the bait at near physiological levels by using the native 
promoter. In Saccharomyces cerevisiae, for example, allele replacement can 
be used to replace the native gene in the yeast genome with the gene that 
encodes the bait protein (Aebersold & Mann, 2003). However, in species where 
allele replacement is not possible, tagged proteins are usually expressed 
transiently. Expression of the tagged proteins allows them to form normal 
physiological complexes that are isolated and purified under mild conditions, 
using one or more affinity steps (Causier, 2004).  
 Protein complexes and their components can be purified subsequently by gel 
electrophoresis or HPLC (High Performance Liquid Chromatography). In the 
case of gel electrophoresis, proteins can be separated in one dimension (based 
on molecular weight) or in two dimensions (based on charge and molecular 
weight). Proteins are stained, and gel slices that contain the individual proteins 
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are excised. These slices are subjected to protease digestion, typically with 
trypsin or Lys-C, to produce characteristic peptide fragments that are analyzed 
with standard MS technologies. Two MS methods are commonly used for 
protein identification. Peptide mass fingerprinting (PMF) uses matrix-assisted 
laser desorption/ionization time-of-flight MS (MALDI-TOF) to determine the 
masses of peptides generated by a tryptic digest. Experimentally determined 
protein masses are compared with a database that consists of peptide 
fragments derived from protein sequences digested in silico with trypsin. 
Experimental proteins are identified by a statistically significant overlap with the 
computer-generated peptide masses. The second method, tandem mass 
spectrometry (MS/MS), uses a combination of peptide mass and sequence 
data for protein identification. The mass of a particular peptide is measured, 
and that peptide is isolated from the mixture within the mass spectrometer. 
Analysis of a number of peptides from the protein digest can be used to confirm 
the identity of the protein (Bauer & Kuster, 2003). 
 
1.3.1.2. Yeast-Two-Hybrid Assay 
The yeast- two-hybrid assay is a powerful method to screen prey-expression 
libraries for proteins that interact with a bait protein (See Figure 1.11). Library 
screens have the potential to generate many interesting interactions. The 
original system described by Fields and Song (1989) was based on the yeast 
GAL4 transcription factor, and is now known as the GAL4 system. A major 
drawback is that a large number of false positives are isolated. 
In this procedure two plasmids are constructed. The bait-encoding protein X is  
fused to the C-terminus of a transcription factor DNA-binding domain (DBD) 
and the prey-encoding protein Y is fused to an activation domain (AD). 
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Alternatively, the prey can consist of proteins encoded by an expression library. 
Each plasmid is introduced into an appropriate yeast strain either by co-
transformation, sequential transformation, or by yeast mating. Only if proteins X 
and Y physically interact with one another are the BD and AD brought together 
to reconstitute a functionally active transcription factor that binds to upstream 
specific activation sequences (UAS) in the promoters of the reporter genes, and 
to activate their expression. 
 
1.3.1.3. Critical Analysis of Yeast-Two-Hybrid Assay and Mass 
Spectrometry as High Throughput Tools 
These two alternative technologies, one (yeast-two-hybrid assay) relying more 
on detection of binary interactions and the other (Mass Spectrometry) relying 
on isolation of protein complexes and identification of all the interacting 
partners, have enabled the detection of thousands of biologically relevant 
interactions. 
Uetz et al., 2000, used the matrix- and library-based yeast-two-hybrid 
approaches to examine the interactions between the proteins encoded by the 
6,000 predicted yeast ORFs.  
Gavin et al., 2002 and Ho et al., 2002 attempted to identify all of the 
components that were present in naturally  generated protein complexes. In 
the case of Gavin et al., 2002, 1,739 genes were expressed with the TAP tag 
and allowed to form natural  complexes under appropriate physiological 
conditions. Ho et al., 2002 expressed 725 proteins (approximately 10% of the 
predicted yeast proteins) modified to carry the FLAG epitope, and complexes 
were purified using a single immunoaffinity purification step.  
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Whereas the Mass Spectrometry based method is more suited for isolation of 
large protein complexes and construction of protein-interaction networks, this 
method is biased towards only stable and abundant complexes that are formed 
inside the cells. In contrast, the yeast-two-hybrid method is more sensitive 
towards detection of binary, transient or weak interactions. 
Both these methods are have generated data which is only partially reliable. Ito 
et al., 2002 analyzed a subset of their two-hybrid data, composed of 415 
interactions, and found that approximately 50% of the interactions were 
biologically significant. 
Gavin et al., 2002 estimated that about 30% of their data was not reliable. 
However, the probability of detecting these interactions has been suggested to 
be three times greater for   Mass Spectrometry than for the yeast-two-hybrid 
(Ho et al., 2002).  
Hence it can be concluded that a number of alternative approaches would have 
to be applied for the characterization of the entire protein-interaction datasets. 
 
1.3.1.4. Protein Chips: Automating Screening  
High throughput sub-cloning of Open Reading Frames of humans (Busow et 
al., 2000) and purification of human proteins from E. coli (Braun et al., 2002) 
has paved way for construction of protein-arrays elucidating novel interactions. 
However, expression of eukaryotic proteins in E. coli has resulted in localization 
of these proteins to inclusion bodies and their denaturation. Therefore 
eukaryotic expression systems, namely Saccharomyces cerevisiae and Pichia 
pastoris, have been adapted for expression and purification of these proteins 
for high throughput analysis of proteins which can be posttranslationally 





Figure 1.10.  Tandem Affinity Purification strategy with the design of C-
terminal and N-terminal TAP tags (left) and the overall complex 
purification procedure (right). (Reprinted from Methods, 24(3), Puig, O. et 
al., The tandem affinity purification (TAP) method: a general procedure of 
protein complex purification, 218-229, 2001, with permission from 
Elsevier) 
  
                       
 
Figure 1.11.  The Yeast Two-Hybrid System. (Reprinted from Methods, 
24(3), Puig, O. et al., The tandem affinity purification (TAP) method: a 
general procedure of protein complex purification, 218-229, 2001, with 




Baculo-virus expression system has been used in 96-well format to express 76 
human cDNAs of which 42 have produced a soluble product (Albala et al., 
2000).  
Protein chips have been used not only for testing antibody-antigen interactions 
but also for screening protein-ligand interactions, where the ligand can be a 
protein, drug, DNA, RNA or enzyme substrate. In one approach, a conserved 
cytoplasmic motif KVGFFKR, from the platelet membrane protein integrin 
tagged with biotin was screened against a high density array of 37,000 E. coli 
clones expressing recombinant human proteins and thirteen different proteins 
were identified as binding the labeled peptide (Larkin et al., 2004). 
A major bottleneck in creating protein arrays is the aim to cover the huge 
diversity of human proteins. A collection of high-quality expression clones is 
required for protein purification and systems for the production of proteins in 
high throughput manner must be developed. The challenge will be to make 
expression methods sufficiently comprehensive such that potentially all proteins 
become available. One important point to note is the lack of control of the 
posttranslational modifications and correct folding of human proteins in these 
set-ups. Currently, the problem is to incorporate posttranslational modifications, 
of which phosphorylation and glycosylation are just two of many, into protein 
arrays. It might be possible to apply Mass Spectrometry to selectively analyze 
the post-translational modifications of imprinted proteins as well as using 






1.3.2. Capturing Protein-Protein-Interactions inside Living Human Cells: In 
vivo Assays 
 
Proteins do not work in isolation inside the cell but in a crowded environment 
where solute concentrations can exceed 400 g/L (Bryant et al., 2005). The 
viscosity of E.coli cytoplasm has been estimated to be 1.2 to 1.5 times higher 
than a normal buffer solution (Bicknese et al., 1993) which has been 
demonstrated to directly affect intracellular dynamics of the apocytochrome b5 
by quantifying {1H}-15N nuclear Overhauser effect (nOe) measurements, which 
characterize motions on the pico- to nanosecond time scale (Bryant et al., 
2005). Hence it can be assumed that the various parameters including 
localization in specific intracellular compartments, ionic states, post-
translational modifications and modifications like phophorylation and 
dephosphorylation in response to signal transduction, can affect the dynamic 
interaction states of proteins in vivo. Therefore it becomes vital to assess 
protein interactions in the closest possible physiological conditions inside the 
cells in order to generate accurate interaction networks. 
 
1.3.2.1. Fluorescence Based Interaction Assays 
Several assays have been devised to test protein interactions inside 
mammalian cells. Fluorescence Resonance Energy Transfer or FRET is 
described an energy transfer mechanism between two fluorescent molecules. A 
fluorescent donor is excited at its specific fluorescence excitation wavelength. 
By a long-range dipole-dipole coupling mechanism, this excited state is then 
nonradiatively transferred to a second molecule, the acceptor. The donor 
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returns to the electronic ground state. The described energy transfer 
mechanism is termed "Förster resonance energy transfer" (FRET), named after 
German Scientist Theodor Förster (Förster, 1965). The efficiency of FRET is 
dependent on the inverse sixth power of intermolecular separation (Förster, 
1965; Clegg, 1996); making it a sensitive technique for investigating a variety of 
biological phenomena that produce changes in molecular proximity, especially 
protein-protein interactions. Protein-protein interactions between cell receptors 
have been analyzed inside living human cells by FRET using variants of the 
Green Fluorescence Protein (GFP) by Siegel et al., 2000. Similarly 
bromodomain proteins and their recognition of acetylated histones have been 
visualized in living cells by Kanno et al., 2004. 
Other fluorescence based in vivo assays include a dual light reporter system to 
determine the efficiency of protein interactions in mammalian cells (Nasim et 
al., 2005) and  magnetic nanoprobe technology (Won et al., 2005) using 
supermagnetic nanoparticles which are biocompatible. These particles can be 
taken up by cells and are used to screen for interacting partners using GFP and 
monomeric RFP.  
 
1.3.2.2. Cell Signalling Based Interaction Assays 
Certain assays have been specifically devised for signaling proteins 
participating in signal transduction. GRIP technology (Terry et al., 2003), for 
example, is based on the distinct translocation behavior of the human cAMP 
phosphodiesterase PDE4A4 where a bait protein is fused to the cAMP 
phosphodiesterase isoform PDE4A4B, which acts as an inducible anchor 
protein, and the prey protein is labeled with GFP. Treatment with the PDE4A4 
inhibitor RS25344 leads to a sub localization of PDE4A4 into compact foci and 
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the interaction between bait and prey constructs is revealed by a redistribution 
of GFP fluorescence to these same foci. 
MAPPIT or Mammalian Protein-Protein Interaction Trap is another cytokine 
receptor based two-hybrid method for detecting interactions in mammalian cells 
(Tavernier et al., 2002). The activation site of the receptor has been eliminated, 
so that no signal can be detected upon ligand binding. However, a fusion 
protein, carrying an activation site can be recruited to the receptor by protein-
protein interaction, and will restore the signaling upon ligand binding leading to 
reporter gene expression. 
 
1.4 Split-Ubiquitin System: A Unique Interaction Assay for 
Transcriptional Proteins 
 
The split-ubiquitin assay was devised as an alternative to the standard yeast-
two-hybrid system (Johnsson et al., 1994). Ubiquitin is a conserved protein of 
76 amino acids, which is usually attached to the N-terminus of proteins as a 
signal for their degradation (Varshavsky, 1997). This molecule is recognized by 
ubiquitin-specific proteases (UBPs), resulting in the cleavage of the attached 
protein. The cleavage can be visualized with a stable reporter protein attached 
to the C-terminus of ubiquitin. In this system, ubiquitin is split into N-terminal 
and C-terminal halves (Nub amino acids 1-34 and Cub, amino acids 35-76 of 
ubiquitin, respectively). The Cub is fused to a reporter protein. Nub and Cub-
reporter fusions assemble in the cell to form the ‘split-ubiquitin”. The interaction 
of the two proteins inside the cells brings the two halves of ubiquitin in close 
proximity with one another. This reconstituted ubiquitin is recognized by the 
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ubiquitin specific proteases (UBPs). The fusion containing Cub reporter is 
cleaved resulting in a protein product of reduced size. In the original design, the 
interaction between the zipper regions of Gcn4 was measured by 
immunoprecipitation and immunoblot analysis of cleaved reporter. This system 
has also been used for the analysis of interactions between membrane proteins 
in vivo (Stagljar et al., 1998). 
The split-ubiquitin system has been developed by for the selection of protein 
interactions inside living human cells (Rojo-Niersbach et al., 2000). Unlike the 
mammalian two hybrid system (Luo et al., 1997), which relies on a 
transcriptional readout to detect protein-protein interactions, the split-ubiquitin 
system is uniquely suited for testing interactions between transcriptional 
proteins as the readout of this assay is based on proteolytic degradation and 
not on transcription. 
In the human split-ubiquitin system, the human fibroblast cell line 
HT1080HPRT- (Pellegrini et al., 1989), sensitive to medium containing HAT but 
resistant to medium containing 6-TG has been used. This deficiency can be 
complemented with the E. coli gene for Gpt2 with an R (arginine) residue 
substituted at the N-terminus to make it amenable for the N-end rule of protein 
degradation. The bait protein can be fused to Cub further tagged to the RGpt2 
reporter. Transfections of these bait proteins into human HT1080HPRT- cells 
make them resistant to HAT  and sensitive to 6-TG. However, co-expression of 
the prey protein fused to Nub along with the bait construct results in degradation 
of the Cub-RGpt2 reporter according to the N-end rule and hence reversal of the 
phenotype of the cells to HAT sensitivity and 6-TG resistance upon protein 
interaction within the cells (See Figure 1.12).  
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This assay has primarily been used as the in vivo protein-interaction assay in 
for human linker histone and core histone proteins (See Chapter three). 
Expression of human proteins inside human cells allows them to fold properly 
and to be posttranslationally modified. It is known that interaction of histones 
with regulatory proteins that control chromatin dynamics is largely dependent 
on the posttranslational modifications. 
Like other two-hybrid systems, the split-ubiquitin assay can not only detect 
protein-protein interactions between members of individual biological 
complexes but can also reveal binary and transient interactions between two 
proteins which are too weak to be picked up by other techniques.  
In Chapter four, an attempt has been made to adapt this system for the 
purpose of screening large scale human cDNA libraries inside living cells using 
Adeno-Associated Viruses for gene delivery and expression. This novel 
protocol can be used to identify new interacting partners for the human linker 










Figure 1.12.  Design of the Split-Ubiquitin System.  
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2.1. Testing Interactions Between Linker Histone and Core Histone 
Proteins Inside Human Cells Using the Split-Ubiquitin System. 
 
 2.1.1. Cloning 
 2.1.1.1. PCR, Restriction and Ligation 
Linker histone hH1 and core histones hH2A, hH2B, hH3 and hH4 were 
amplified from human cDNA (see Table 2.1 for cDNA source and histone NCBI 
reference sequence) with the help of high fidelity Pfu polymerase using the 
following primers: 
5’hH1-MunI:           5’- GCCGCCCAATTGATGACCGAGAATTCCACGTC-3’ 
3’hH1-go-XhoI:      5’- GCCGCCCTCGAGAAAAGGGTGGCTTTGGGTTT-3’.  
5’hH2A-EcoRI:       5’- GCCGAATTCATGTCTGGTCGTGGCAAGCA-3’ 
3’hH2A-stop-Sal I  5’- GCCGCCGTCGACTCACTTGCCCTTTGCCTTGT-3’ 
5’hH2B-MunI:        5’- GCCGCCCAATTGATGCCAGAGCCAGCGAAGTC-3’ 
3’hH2B-stop-SalI:  5’- GCCGCCCTCGAGTTCCTTAGCGCTGGTGTACT-3’ 
5’hH3B-EcoRI:      5’- GCCGAATTCATGGCTCGTACAAAGCAGAC-3’ 
3’hH3B-stop-XhoI: 5’- GCCGCCCTCGAGTTAAGCAGCACGTTCTCCACGTA-3’ 
5’hH4-EcoRI:         5’- GCCGAATTCATGTCTGGCCGCGGCAAAGG-3’ 
3’hH4-stop-XhoI:   5’- GCCGCCCTCGAGTCAACCACCGAAACCGTAGA-3’ 
Each reaction was carried out by mixing the contents according to Table 2.2. 
Amplification of DNA was carried out using the Expand High Fidelity PCR 
system (Boehringer Mannheim). The components of each tube were prepared 
as indicated in Table 3.  The samples were amplified for 35 cycles. First, the 
cycler was preheated at 94ºC for 2 minutes before amplification began. Then 
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the program for each cycle started at 94°C for 1 minute, followed by 50°C for 1 
minute, and 72°C for 3 minutes. 
 The samples were then cooled at 4°C before performing electrophoresis on an 
agarose gel. 1.5% agarose gel containing ethidium bromide was used to 
visualize the PCR products under UV-light (GeneGenius, Syngene).  
The PCR products were purified using High Pure PCR Purification Kit 
(Boehringer Mannheim) following the manufacturer’s protocol. 
The PCR products were restricted with EcoRI/MunI and XhoI/SalI according to 
the restriction enzyme sites incorporated into the primers. The reaction was 
carried out at 37ºC in a total volume of 100µl, consisting of 50µl of the PCR 
product, 10µl of Restriction Enzyme Buffer and 1µl of each restriction enzyme.  
After purification of the restricted fragments, a ligation reaction was carried out 
according to Table 2.3 pcDNA3.1/Zeocin (containing CubRGpt2) and 
pcDNA3.1/Neomycin (containing Nub) plasmids (Invitrogen and Rojo-Niersbach, 
2000) restricted with EcoRI and XhoI were used for cloning the PCR products. 
The vector maps can be seen in Figures 2.1 and   2.2. These inserts were also 
cloned into pAAV-Nub (Stratagene) restricted with EcoRI and XhoI using the 
same protocol as above. 
 
2.1.1.2. Transformation of DH5  cells 
To the 10 µl of ligation mix, 50 µl of competent DH5  E. coli cells were added 
and stored on ice for 15 minutes. They were then heat shocked for 90 seconds 
at 42°C in a water bath. 200 µl of Luria Bertani (LB) without any antibiotic was 
added to the cells, which were then incubated at 37ºC for one hour. The cells 







Single colonies were picked from LB+Ampicillin plates and inoculated into 2ml 
of LB Ampicillin (50mg/ml) broth in glass test tubes. The culture was grown in a 
shaker at 37°C overnight. The culture from each test tube was then transferred 
to 1.5ml a microcentrifuge tube and centrifuged at 13,000 RPM for one minute. 
The supernatant was discarded and 200 µl of Miniprep Solution I was added to 
the pellet. After thoroughly mixing the pellet, 200 µl of Solution II was added 
and the tube was gently inverted six times to mix the contents. 200 µl of 
Solution III was also dispensed into each tube and the contents were mixed by 
gently inverting the tube six times again. The cell lysate obtained was 
centrifuged at 13,000 RPM for 10 minutes.    
The supernatant was then transferred into new tubes and 300 µl of isopropanol 
was dispensed into each tube. The tubes were agitated vigorously. This mixture 
was centrifuged at 13,000 RPM for 10 minutes. The supernatant was discarded 
and 1ml of 70% ethanol was added to the pellet and the tubes were centrifuged 
at 13,000 RPM for five minutes. The ethanol was drained on a tissue paper and 
the pellet was dried in a speed vac for 30 minutes.  The pellet was then re-
suspended in 50 µl of distilled H2O, mixed well and subsequently stored at -
20°C.Positive clones were verified by restriction digest with HindIII and EcoRV 
enzymes (for pcDNA-CubRGpt2) and BamHI and SmaI (for pcDNA-Nub). The 











Figure 2.1. Map of pcDNA3.1 (+) /Zeocin vector (from Invitrogen website). 
EcoRI and XhoI restriction sites were used for the cloning of the PCR 




Figure 2.2  Map of pcDNA3.1/Neomycin vector (from Invitrogen website). 
EcoRI and XhoI restriction sites were used for the cloning of the PCR 










2.1.1.4. Checking for positive clones 
Positive clones were verified by restriction digest with HindIII and EcoRV 
enzymes (for pcDNA-CubRGpt2) and BamHI and SmaI (for pcDNA-Nub). The 
restriction reaction was carried out according to Table 2.4. 
The restriction products were analyzed on 1% agarose ethidium bromide gel 
and visualized under UV-light in GeneGenius, Syngene Instrument. 
 
2.1.1.5. DNA Sequencing 
The positive clones obtained were sequenced using the following primers: 
T7 (for sequencing EcoRI junction of inserts cloned into pcDNA3-CubRGpt2 ): 
5’- TAATGCGACTCACTATAGGG-3’ 
Cub-50(for sequencing the XhoI junction of inserts cloned into pcDNA3-
CubRGpt2): 5’- CAGACAGCGTTCTACCGTCT-3’  
Nub129 (for sequencing the EcoRI junction of inserts cloned into pcDNA-Nub): 
5’-GGATCCCTCCAGGTAACTCG-3’ 
TcDNA3-50 (for sequencing the XhoI junction of inserts cloned into pcDNA3-
Nub):5’-GGGGAGGGGCAAACAACAGA-3’ 
Cycle sequencing reaction using primers listed above was carried out, followed 
by the purification of the extension products. To 250ng of template DNA, 
1.6pmol of primer and 4µl of Terminator Ready Reaction Mix was added. The 









Table 2.2.  PCR Reaction Mix per sample.          
Reagent Volume(µl) for 1 
sample Final Concentration 
10 X PCR Buffer with MgCl2 5 1X 
Dntp 1 0.2mM 
Forward Primer  variable 50µM 
Reverse Primer variable 50µM 
Sterile water variable - 
High fidelity polymerase 0.5 1-unit 
Total Volume  50µl - 
 
Table 2.3. Ligation Reaction per sample. 
Reagent 




10X Ligase Buffer 1 
Sterile water 4.5 
Restricted Insert DNA 3 
T4 DNA Ligase 0.5 
Total Volume 10 
 
Table 2.4. Restriction Digest to Screen for Positive Inserts. 
Reagent 
Volume(µl) for 1 
sample 
Restriction Buffer 2.5 
Plasmid DNA 5 
Sterile water 17 
Restriction Enzyme 1 0.25 
Restriction Enzyme 2 0.25 
Total Volume 25 
 
 
Table 2.1. Human Histones amplified by PCR from the indicated human cDNA sources. 
Histone  Type/variant NCBI Reference Number cDNA Source 
H1 member O NM_005318 HeLA 
H2A  H2aa NM_03516 HeLA 
H2B H2bk BC_08767 HeLA 
H3 H3b NM_003537 B-Cell 




The following cycling parameters were used: 
96°C for 30 seconds 
50°C for 15 seconds 
60°C for 4 minutes  
Upon completion of the reaction, the contents were transferred into 1.5ml 
microcentrifuge tubes that contained 80µl of ethanol/sodium acetate solution 
(consisting of 3.0µl 3M sodium acetate, pH4.6, 62.5µl of non denatured 95% 
ethanol and 14.5µl of deionized water). The micro tubes were vortexed 
briefly and left at room temperature for 15 minutes to precipitate the 
extension products. Next, the tubes were centrifuged at 13,000 RPM for 10 
minutes, and the supernatants were carefully aspirated and discarded. 
500µl of 75% ethanol was added to rinse the pellet, and tube was 
centrifuged at 13,000 RPM for 5 minutes. The supernatants were discarded 
and the pellets were dried in a speed-vacuum concentrator for 10 minutes. 
Subsequently, the dried samples were sent to the Sequencing Facility at the 
Department of Microbiology, National University of Singapore. 
Sequence analysis was performed at the NCBI website using the “Align Two 
Sequences” option.  
 
2.1.2. Cloning into pCMV-myc plasmids 
 
For cloning into pCMV-myc plasmid (BD Biosciences, Clontech, and Figure 
2.3), the following primers were used to clone histones in frame with myc 




5’hH1-MunI-gly:         5’-GCCGCCCAATTGGGATGACCGAGAATTCCACGTC-3’ 
3’hH1-stop-XhoI:       5’-GCCGCCCTCGAGTTAAAAAAGGGTGGCTTTGG-3’ 
The PCR products were purified and digested with MunI/EcoRI and 
XhoI/SalI and ligated into pCMV-myc (Invitrogen) accordingly. The protocol 
followed was the same as above. The screening for positive inserts was 
done using NotI and SspI restriction enzymes. Cycle sequencing reaction 
was performed using the 5’ and 3’ primers that had been used for cloning of 
inserts. 
 
2.1.3. Plasmid Purification Using QIAfilter Plasmid Midi Kit 
 
For positive miniprep samples whose sequences had been verified, 
retransformation was performed using 0.5 µl of the plasmid and 10 µl of 
DH5  cells. Single colonies were picked and inoculated into 25ml of LB 
(Luria Broth) with Ampicillin and incubated at 37°C, overnight in a shaker.  
The cells were harvested the next day by centrifuging them in 250ml bottles 
at 8,000 RPM, 5 minutes, 4°C. The bacterial pellet was resuspended in 4ml 
Buffer P1 (QIAGEN).  The bacteria were resuspended completely by 
vortexing and pipeting up and down until no cell clumps remained. 4ml of 
Buffer P2 was added to the lysate and was mixed gently by inverting the 
bottle 4-6 times. The lysate was incubated at room temperature for 5 
minutes. 4ml of chilled buffer P3 to the lysate, and mixed immediately but 
gently by inverting 4-6 times. This lysate was then transferred to 50ml tubes 
and centrifuged at 18,000 RPM for 20 minutes at 4°C. In the meanwhile, a 
QIAGEN-tip 100 was equilibrated with 4ml of Buffer QBT which was allowed 









Figure 2.3 Map of pCMV-Myc Vector used for Co-Immunoprecipitation 
(from BD Biosciences website). 














The cleared supernatant was then transferred into the tip and allowed to 
enter the resin by gravity flow. Subsequently, the QIAGEN tip was washed 
twice with 10ml buffer QC. DNA was eluted into 15ml falcon tubes with 5ml 
buffer QF. The DNA was precipitated by adding 3.5ml isopropanol to the 
eluted DNA and centrifuging at 10,000 RPM for 20 minutes at 4°C. The 
supernatant was carefully decanted and the pellet was washed with 2ml of 
70% ethanol at 10,000RPM for 10 minutes. After discarding the 
supernatant, the pellet was dried under vacuum and dissolved in 100µl of 
sterile water. The integrity of the purified plasmid DNA was verified by 
restriction digest and agarose gel electrophoresis. 
 
2.1.4. Cell lines and transfections 
 
The human fibroblast cells HT1080HPRT- deficient for the enzyme for 
hypoxanthine- guanine phosphoribosyl transferase (HPRT) kindly provided 
by Sandra Pellegrini (Pellegrini et al., 1989), were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% FCS and 1% 
Pencillin-Streptomycin (Sigma) in 75cm2 tissue culture flasks. The cells were 
incubated at 37ºC with 5% CO2. 10% DMSO was used for making stocks 
which were stored at -80ºC. Cells were passaged when they reached a 
confluency of around 80%. 
HEK293 cells were cultured similarly except that the medium was also 






2.1.4.1. Construction of Cell Lines Expressing hH1-CubRGpt2 : 
 HT1080HPRT- cells were trypsinized from tissue culture flasks and 105 cells 
were plated onto 6-well plates and allowed to reach around 70-80% 
confluency on the day of the transfection. 0.5µg of expressing 
pcDNA3.1/Zeocin plasmid expressing hH1-CubRGpt2, purified using a 
QIAgen tip was transfected into cells in each well using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s protocol. In brief, 0.5µg of the 
plasmid DNA was diluted in 100µl of serum free DMEM medium. 3µl of 
lipofectamine was mixed in 100µl of DMEM in a separate tube. The two 
solutions were then combined and incubated at room temperature for 15 
minutes to allow the formation of lipofectamine-DNA complexes. Meanwhile, 
the cells in the 6-well plates were washed gently with 2ml serum free 
medium. 800µl of serum-free DMEM was added to the mixture and the 
diluted complexes were transferred onto the washed cells. The cells were 
incubated for five hours at 37ºC with 5% CO2 inside an incubator. 1ml of 
DMEM with 20% FCS and 1% Penicillin-Streptomycin solution was added to 
the cells without removing the transfection mixture. The cells were 
incubated for an additional 48 hours. After 48 hours, the medium was 
aspirated from the wells and the cells were washed with 2ml PBS in each 
well. 0.5ml of Trypsin-EDTA solution was added to trypsinize the cells. 
Trypsin was neutralized by adding 2ml of DMEM+10%FCS+1%Pencillin-
Streptomycin (PS). The cells were re-suspended by pipeting the medium up 
and down. 400µl of cells were distributed into each well of six-well plates, 
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leaving behind 100µl of cell suspension behind. These cells were further 
diluted by topping up the volume to 2.5ml and re-distributing the contents 
into the wells of another six-well plate. The procedure was repeated once 
more. Cell suspensions were mixed with 2ml of DMEM supplemented with 
10%FCS, 1%PS and zeocin (80mg/ml) as described (Rojo-Niersbach et al., 
2000). After incubating the plates in the incubator at 37ºC with 5% CO2 for a 
period of two weeks single colonies were obtained. These colonies were 
trypsinized by using cloning rings. The cells from each colony were 
transferred to a single well and expanded in the same selective medium. 
When around 80-90% confluency was reached the cells from each well 
were trypsinized and 250µl of cells were distributed   into 6-well plates 
containing 2ml of each: 
1. DMEM+10%FCS +1%PS 
2. DMEM+10%FCS+1%PS+Hypoxanthine aminopterin/thymidine (HAT) 
made according to the manufacturer’s protocol (Roche)  and  
3. DMEM+ 10%FCS+1%PS+ 6-thioguanine(6-TG) medium(15mg/l) 
(Sigma, Deisenhofen, Germany)+ zeocin (80mg/l) 
After a week, the cells were photographed using an Olympus1X70 inverted 
microscope with an attached digital camera. 
 
2.1.4.2. Co-expression of Nub constructs with hH1-CubRGpt2 inside 
HT1080HPRT- cells 
Stable cell lines created previously expressing hH1-CubRGpt2 inside 
HT1080HPRT- cells were seeded into 6 well plates and the transfection 
procedure using pcDNA3.1/Neomycin plasmids, with Nub inserts, was 
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repeated as described above.  Cells were subsequently selected in G418. 





For Western-blotting, untransfected HT1080HPRT- cells or HT1080HPRT- 
cells expressing hH1-CubRGpt2 together with Nub fused to core histones 
hH2A, hH2B, hH3 and hH4 were grown in 75cm2 tissue culture flasks. After 
reaching 70-80% confluency, cells were trypsinized with Trypsin/EDTA 
solution and centrifuged at 1,500 RPM for 5 minutes to pellet the cells. The 
cells were then washed once with phosphate-buffered saline (PBS) solution 
and lysed with 500µl of CellLyticTM Buffer (Sigma) containing freshly added 
1mM PMSF. The cell lysate was also incubated with DNase and MgCl2   for 
30 minutes at room temperature. The lysed cells were centrifuged at 13,000 
RPM for 15 minutes to pellet the cellular debris. The protein containing 
supernatants were transferred to chilled tubes and subsequently stored at 
minus 80°C.  
10µl of each of the protein sample was mixed with 2X loading dye (Bio-Rad 
laboratories) and heated to 95ºC for five minutes in a heat block. 5µl of the 
Kaleidoscope Prestained Standards (Bio-Rad Laboratories) was also loaded 
onto the gel as a molecular weight marker. Samples were then separated 
on 12% SDS-PAGE gel and the proteins were transferred onto ImmunBlot 
PVDF Membrane (Biorad) of 0.2µm pore size. A Semi-Dry Electrophoretic 
Transfer Cell was used for blotting the membrane. A sandwich was 
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assembled by placing five pieces of filter papers presoaked in 1X Transfer 
Buffer onto the platinum anode, followed by the pre-wet PVDF membrane, 
the gel and five more pieces of soaked filter paper. Air bubbles were 
carefully removed from between each layer. After the cathode and safety 
cover were placed onto the stack, the electrophoretic transfer was 
performed at 2mA per cm2 for 90 minutes. The membrane was then placed 
in blocking buffer containing 5% milk with 0. 01M Tris-HCl (pH 7.5) for one 
hour. In the next step, the blot was immunoprobed with antibody to the HA 
tag, using 5µl of anti-HA11 (1:2,000 dilution, BabCO, Freiburg, Germany) in 
5% non-fat milk and TBST. After overnight incubation, the membrane was 
washed with TBST three times for 15 minutes. 2.5µl of Horseradish 
peroxidase-conjugated anti-mouse antibody (1:4,000 dilution, Bio-Rad, 
Germany), dissolved in 5% non-fat milk and TBST, was used as the 
secondary antibody. The membrane was incubated for two hours in the 
secondary antibody, followed by washing three times with TBST for 15 
minutes. Signals were detected using Luminol solutions A and B (ECL Plus, 
Amersham) in a ratio of 40:1. The mixed reagent was allowed to incubate 
for 1 minute. The membrane was subsequently placed in between two 
transparencies in an X-ray film cassette. The film was developed in the dark 




Human HEK293 cells were grown in 100mm tissue culture plates up to a 
confluency of 70 to 80%. These cells were co-transfected with 4.0µg of 
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pCMV-myc plasmid expressing myc-tagged hH1 along with one of the 
following plasmids- pAAV-Nub-hH2A, pAAV-Nub-hH2B, pAAV-Nub-hH3, pAAV-
Nub-hH4 containing HA-tagged core histones. pCMV-myc-hH1 was also 
transfected alone into HEK293 cells. Lipofectamine 2000 (Invitrogen) was 
used for all the transfections carried out according to the manufacturer’s 
protocol. After two days (transient transfection), the cells were trypsinized 
and pelleted at 1,500 RPM for five minutes. The pellets were washed in 
phoshphate buffered saline (PBS) after which they were thoroughly lysed 
with 500µl CellLyticTM buffer (Sigma) along with freshly added 1mM PMSF as 
protease inhibitor. The cells were also subjected to DNase treatment for 30 
minutes in the presence of MgCl2. Centrifuging the lysate at 4°C at 13,000 
RPM for 10 minutes pelleted the cell debris. The lysates were stored at -
80°C for subsequent use. For verifying expression of myc-tagged hH1 and 
HA-tagged core histones, 10µl of samples were mixed with 2X loading dye, 
boiled for 5 minutes and separated on two separate 12% SDS PAGE gels. 
The gels were blotted onto PVDF membranes as mentioned above. The 
membranes were probed with anti-HA11 antibody (1:2,000 dilution, BabCO, 
Freiburg, Germany) and anti-myc (1:5,000 dilution) primary antibodies 
respectively. Horse Radish-Peroxidase conjugated anti-mouse secondary 
antibody was also used (1:4,000 dilution). Bands were detected using ECL 
Plus (Amersham) as described above. 
10µl of anti-HA antibody coupled to sepharose beads (Covance) were first 
equilibrated with equal volume of cell lysis buffer. 10µl of this slurry was 
incubated with 100µl of cell lysate for two hours in a rotor at 4°C. The beads 
were then pelleted by centrifugation at 13,000 RPM for 1 minute at 4°C and 
were subsequently washed thrice, with 250µl lysis buffer. The samples were 
 
73
mixed with 2X SDS loading dye, boiled and separated on two 12% SDS 
PAGE gels. The proteins were transferred onto ImmunBlot PVDF 
Membranes (Biorad) of 0.2µm pore size, blocked with 5% milk powder in 
0.01M Tris-HCl (pH 7.5) and immunoprobed with anti-HA11(1:2,000 dilution, 
BabCO, Freiburg, Germany) and  anti-myc (1:5,000 dilution) antibody. 2.5µl 
of Horseradish perodixase-conjugated anti-mouse antibody (1:4,000 
dilution, Bio-Rad Germany) was used as the secondary antibody. Signals 
were detected in the same manner as described above. 
 
2.1.7. Molecular Modeling 
 
The nucleosome structure and linker histone were modeled using PyMol 
software. pdb files 1AOI (Luger et al.,1997) and 1GHC (Cerf et al.,1993) 
were downloaded from NCBI using Cn3D 4.1 software. Alignments were 
made according to biochemically established interactions of linker histone 
with nucleosomal DNA (Bharath et al., 2003) using PyMOL. Amino acid 
residues 67, 69, 73, 85 which form a basic cluster on one end were shaded 
red, while residues 40 and 42 which form the second DNA binding site on 
the opposite end were shaded orange. 
 






Nub was cloned in 3 reading frames into pAAV-IRES-hrGFP plasmid (AAV 
Helper Free System, Stratagene, and Figure 2.4.) and Restriction Enzymes 
ClaI and EcoRI using the following primers for amplification of Nub: 
5’-N
ub-ClaI:               5’-  GCCGCCATCGATATGCAGATTTTCGTCAAGAG-3’ 
3’-N
ub -EcoRI-1:        5’-  GCCGAATTCAGCGTAATCTGGAGGATC-3’ 
 3’-N
ub -EcoRI-2:       5’-  GCCGAATTCCCAGCGTAATCTGGAACAT-3’ 
 3’-N
ub -EcoRI-3:       5’-  GCCGAATTCCAGCGTAATCTGGAACAT-3’ 
      pACNX-Nub-cDNA library was used as a template. 
Human Histones hH3, hH4 and hProthymosin were also cloned in the first 
reading frame with Nub   using the following primers and Restriction Enzymes 
EcoRI and XhoI : 
 5’-hH3-EcoRI:                5’- GCCGAATTCATGGCACGCACGAAGCAAAC-3’ 
 3’-hH3-XhoI(stop):         5’- GCCGAATTCATGGCTCGTACAAAGCAGAC-3’ 
 5’-hH4-EcoRI:                5’- GCCGAATTCATGGGGCACTACGTCTTAGC -3’ 
 3’-hH4-stop-XhoI:          5’- GCCGCCCTCGAGTCAACCACCGAAACCGTAGA-3’ 
 5’-hProthymosin-EcoRI: 5’- GCCGAATTCATGTCAGACGCAGCCGTAGA-3’ 
 3’-hProthymosin-XhoI-stop: 5’-GCCGCCCTCGAGCTAGTCATCCTCGTCGGTCT-
3’ 
The templates used were the same as described previously (Table 2.1). 
Sequencing of the 5’ end was carried out using Nub129 primer described 
previously. The 3’ primers which were used for cloning the inserts were also 
used for sequencing the plasmids from the 3’-end.  
 




AAV-293 cell stocks provided by Stratagene were thawed and transferred 
into 75cm2 flask containing 24ml DMEM supplemented with 10%FCS, 1% 
PS and 2mM L-glutamine. Cells were passaged when the culture reached 
50% confluence.  In brief, the growth medium was aspirated and the cells 
were washed with 25ml PBS. The cells were then treated with trypsin-EDTA 
solution and incubated for five minutes. 10ml of medium was added to the 
cells which were suspended uniformly by pipeting them up and down three 
to four times.   
500µl of the cell suspension was added to each well in a six-well plate. After 
topping up the volume of medium in each to 2ml the cells were incubated at 
37°C in 5% CO2 until a confluency of 70-80% was achieved.  
The pAAV-IRES-hrGFP constructs along with pAAV-RC and pHelper (AAV 
Helper-Free System, Stratagene, (See Figure 2.4 for vector maps) were 
purified by the Column Purification according to the Manufacturer’s protocol 
(QIAGEN). 250ng of each plasmid, i.e. pAAV- Nub -IRES-hrGFP alone or Nub 
fused to  human hH3/hH4/hProthymosin in combination with pAAV-RC and 
pHelper (Stratagene) was transfected into AAV-293 cells in the six-well 
plates using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol. pAAV-LacZ was also co-transfected with pHelper 
and pAAV-RC plasmids to synthesize pAAV-LacZ carrying stocks, for viral 
titer determination in later steps. The cells were incubated for 5 hours in 
serum-free medium at 37˚C and 5% CO2 after which they were 
supplemented with DMEM containing 18% FCS, 1%PS and 2mM L-




                            
 
                               
 
Figure 2.4. Vector Maps of pAAV-IRES-hrGFP, pAAV-RC and pHelper 
(reprinted with permission from Stratagene).These plasmids were co-




2.2.3. Viral Stock Production  
 
Viral Production was monitored by a observing a change in the color of the 
medium from red to orange or yellow and rounding up and floating of cells in 
the medium. For viral stock preparation the cells were scraped off from the 
plates and the 2ml suspension transferred into 2ml micro tubes.  
   
2.2.4. Viral Infection 
 
HT1080HPRT- cells expressing hH1-CubRgpt2 were plated on 6-well plates and 
grown to 80% confluency at 37˚C, 5% CO2 in DMEM, 10% FCS and 1%PS. For 
viral stock application, the medium was aspirated and 1ml of each viral stock 
for either Nub alone or Nub fused to hH3/hH4/hProthymosin was applied to the 
cells. The plates were swirled gently at 30-minute intervals at 37˚C for 90 
minutes. 1ml of pre-warmed DMEM with 2XFCS was added subsequently and 
the cells were incubated 3 to 4 days. Expression of stably integrated viral 
plasmid DNA was monitored by looking at GFP expression under inverted 
fluorescence microscope. 
For viral titer determination, the primary viral stocks for pAAV-LacZ plasmid 
were diluted 100 fold. From this 100 fold dilution 5-fold serial dilutions were 
made accordingly (10-2, 2 x 10-3, 4 x 10-4 and 8 x 10-5). These dilutions were 
added to each well of HT1080HPRT- cells growing in 6-well plates. After 
adding 1ml of pre-warmed DMEM containing 18% FCS, 1%PS and 2mM L-
glutamine to each well and incubating the cells for another 48 hours at 37°C, 
infected cells were detected by X-gal staining.  The medium was aspirated 
from the cells and 2ml of freshly prepared 1X fixing solution (In Situ - 
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Galactosidase Staining Kit, Stratagene) was added to cells and incubated for 
10 minutes at room temperature. 2ml of freshly prepared 1X staining solution 
was added to the cells, which were then incubated overnight at 37°C in a 
humidified incubator. After incubation, the staining solution was removed and 
the cells were washed three times with 2ml PBS. The cells were analyzed 
under an inverted light microscope and the number of blue cells was counted 
per field. 
The titer was calculated according to the following formula: 
IFU/ml = infected cells per field x fields per well/ volume of virus x dilution 
factor.  
Fields per well = 358 
Volume of virus stock dilution added = 1ml 
 
2.2.5. Fluorescence Activated Cell Sorting (FACS) 
 
Cells expressing GFP di-cistronically with Nub alone or Nub fused to human 
hH3/hH4/hProthymosin were isolated by flow Fluorescence Activated Cell 
Sorting Analysis. In brief, cells were first collected in sterile tubes. Uninfected 
cells were taken as negative control and the auto fluorescence was 
subtracted from of analysis of cells expressing GFP. Next, the GFP 
expressing cells were appropriately gated to isolate them. Cells were sorted 
into 24-well plates at a density of 50 cells per well. After allowing a recovery 
period of 2 days, cells were transferred into medium containing 6-TG and 
zeocin to select HT1080HPRT- cells showing positive protein-protein 
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interactions. This procedure was carried out in National University Medical 
Institute (NUMI), FACS facility at the National University of Singapore. 
 
2.2.6. PCR and Sequencing for Detecting Stably Integrated Viral DNA. 
 
The colonies that arose in 6-TG were trypsinized and expanded first in 6-well 
plates and subsequently into 75cm2 flasks. Genomic DNA was isolated from 
these cells by phenol-chloroform extraction. In brief, cells were grown in 
75cm2 tissue culture flasks to 80-90% confluency. These cells were then 
pelleted and washed with 10 ml PBS by centrifugation at 1,500 RPM for 5 
minutes at room temperature. Cells were re-suspended in one volume 
(usually 200µl) of cell digestion buffer (100mM NaCl, 10mM Tris.HCl, 25mM 
EDTA, 0.5% SDS and 0.1mg/ml Proteinase K which was added fresh). The 
samples were incubated at 50°C overnight in tightly capped tubes. One 
volume of Phenol-Choloroform-Isoamyl alcohol (25: 24: 1 
volume/volume/volume) was added to the cell lysate and the suspension was 
vortexed vigorously. The lysate was centrifuged at 13,000 RPM for 5 minutes. 
The upper phase was transferred to a new microcentrifuge tube and the 
extraction procedure was repeated three times. The upper phase was taken 
into a fresh tube and precipitated by adding ½ volume of 7.5M ammonium 
acetate and 2 volumes of 100% ethanol. The tube was centrifuged at 13,000 
RPM for another 5 minutes.  The pellet was rinsed with 70% ethanol by 
centrifugation at the same speed as in the previous step. The pellet was dried 
under speed-vacuum and re-suspended in 50µl of TE Buffer until dissolved.  
10 µl of each sample was mixed with 2 µl of loading buffer and separated on 
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a 1% agarose gel containing ethidium bromide to check the intactness of the 
genomic DNA isolated. 
PCR was performed with the following primers to amplify the stably integrated 
viral plasmid DNA using 5-10 µl of genomic DNA as template in a 50 µl PCR 
Reaction Volume described earlier: 
pAAV-IRES-hrGFP-R: 5’-GGGGGTAACCCTATGCAGTC-3’ 
pAAV-IRES-hrGFP-L: 5’-TCTTCCGATACCATCGACAA-3’ 
PCR Products were purified as described before.  
Sequencing Reactions were carried out with the Nub129 primer using the 
purified PCR product as template. 
Sequences retrieved were then used to search the NCBI data base for 
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Nucleosomes are the smallest units of chromatin in eukaryotes. They consist of 
the four histone proteins H2A, H2B, H3 and H4 assembled into an octamer 
complex which has 146 base pairs of DNA wrapped around it (Kornberg, 1977 
and McGhee et al., 1980). There are numerous mechanisms operating inside 
eukaryotic cells that regulate nucleosomal mobility during transcription, DNA 
replication and DNA repair (Narlikar et al., 2002). These include ATP-
dependent remodeling (Tyler and Kadonaga, 1999), nucleosomal assembly 
and disassembly by histone chaperones (Tyler and Kadonaga, 1999; Munakata 
et al., 2000; Philpott et al., 2000; Mello et al., 2001; Tyler et al., 2001), histone-
variant exchange (Ahmad and Henikoff, 2002) and covalent modifications of 
histone proteins specifying the “histone-code” (Turner, 2002; Strahl and Allis, 
2000). According to the “histone-code” hypothesis, the formation of distinct 
higher order structures such as euchromatin and heterochromatin is largely 
dependent on local concentration and combination of modified histones leading 
to the formation of different epigenetic states and cell fates.  
Binding of specific factors like the HMG proteins, HP1, Inositol phosphate 
(Rando et al., 2003) and last but not the least, histone H1 to the surface of the 
nucleosomes also induces changes in chromatin architecture. Histone H1 lies 
outside the basic nucleosomal structure and has been termed as the “linker 
histone”, due to its inherent property of linking two adjacent nucleosomes via 
the linker DNA (Thoma et al., 1979 and Simpson, 1978). This leads to the 
formation of a condensed structure termed as the chromatosome. Besides 
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being localized to condensed chromatin regions, H1 is also involved in 
dynamically binding to decondensed chromatin in living cells (Lever et al., 
2000). The duration of H1 binding in vivo is modulated by protein 
phosphorylation and dephosphorylation. Prolonged treatment with ATP-
depleting reagents significantly reduces the mobility of H1 present in chromatin. 
Recently, a number of phosphorylation sites in histone H1 have been identified 
by mass spectrometry (Cosgrove et al., 2004), raising the possibility of the 
extension of histone-code to the linker histone H1 lying outside the core group 
of histones 
H1 might also facilitate heterochromatin assembly as it has been shown to 
interact directly with the major heterochromatin architectural protein HP1 
(Nielsen et al., 2001). Other regions of chromatin like the 5S rRNA genes in 
Xenopus laevis (Pruss and Wolffe, 1993) are transcriptionally regulated by the 
histone H1.  
Due to the lack of concrete structural data of the chromatosome, the position 
and orientation of the linker histone with respect to the nucleosomal DNA and 
core histone proteins is still not certain (Crane-Robinson, 1997). In an effort to 
understand the position of the linker histone, certain methods like protein-DNA- 
photo-cross linking (Zhou et al., 1998) and molecular modeling (Bharath et al., 
2003) have been employed. These methods have highlighted the orientation of 
the linker histone with respect to the linker, histone H2A and nucleosomal DNA 
lying exterior to the octamer complex. Two models have been proposed for the 
orientation of the linker histone. The first model (Zhou et al., 1998) places the 
linker histone over the dyad axis of symmetry where the DNA enters and exits 
the nucleosome. The high concentration of backbone phosphates generates a 
dense patch of negative charge creating a good binding site for the arginine 
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and lysine residues of H1 by means of electrostatic interactions. On the other 
hand, the off-dyad axis model (Pruss and Wolffe, 1993) visualizes the binding 
of the globular domain to the major groove of nucleosomal DNA 60-70 base 
pairs from the dyad axis through the winged-helix motif, while the secondary 
DNA binding site does not contact the DNA of the nucleosome. In both models, 
the largest problem to interpreting the available data has been to assign the 
location of the histone octamer and its constituent core histones (Vignali et al., 
1998). 
 We have demonstrated that the human linker histone H1 interacts directly with 
human core histone proteins H3 and H4. These core histones are located at the 
centre of the octamer complex aligned with the dyad-axis of symmetry forming 
the H3-H4 tetramer complex. We have used the two component split-ubiquitin 
system in human HT1080HPRT- cells to establish these interactions. This 
system allows the determination of protein-protein interactions directly inside 
human cells, which means that the histone proteins can be subject to 
posttranslational modifications. Co-immunoprecipitation has further helped us 
to validate these interactions. Molecular modeling performed by PyMOL has 
enabled us to test our predictions in the context of the nucleosome. These 
results highlight the importance of linker histone in regulating the exposure of 





Linker Histone hH1 Interacts directly with core histones hH3 and hH4 inside 
Human HT1080HPRT- cells- The split-ubiquitin system (Figure 1.9.) is a 
fragment complementation protein-protein interaction assay.  Ubiquitin is split 
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into Nub (N-terminal half) and Cub (C-terminal half). Guanine phosphoribosyl 
transferase (Gpt2) is fused to Cub as a reporter in this human cell line based 
system. Transfection of a pcDNA3.1/Zeocin plasmid containing a bait-protein 
cloned in frame with CubRGpt2 into HT1080HPRT
-
 cells results in HAT 
resistance and 6-TG sensitivity.  Co-expression of an interacting protein fused 
in frame with Nub reconstitutes a ubiquitin-like molecule inside HT1080HPRT
-
 
cells. This ubiquitin-like molecule is recognized and the reporter RGpt2 is 
cleaved off by the ubiquitin-specific proteases. The free RGpt2 is degraded by 
these enzymes according to the N-end rule, resulting in the appearance of HAT 
sensitivity and 6-TG resistance in HT1080HPRT- cells. 
The HT1080HPRT- cells were initially transfected with a pcDNA3.1/Zeocin 
vector expressing hH1-CubRGpt2. The linker histone used in these experiments 
is the extreme somatic variant H1(0), found exclusively on the chromatin of 
terminally differentiated cells (Zlatanova and Doenecke, 1994). Two 
independent cell lines were obtained after selection in zeocin upon transfection 
of HT1080HPRT- cells with the pcDNA3.1-hH1-CubRGpt2 plasmid. These cell 
lines were HAT resistant and 6-TG sensitive.  Expression of the hH1-CubRGpt2 
fusion protein was verified by Western-blot (Figure 3.1). One cell line was 
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Figure 3.1. Phenotype testing and Western-blot analysis of HT1080HPRT- 
cells expressing hH1-Cub-RGpt2. 
A. Two independent colonies were obtained after selection in zeocin upon 
transfection of HT1080HPRT- cells with pcDNA3.1-hH1-CubRGpt2 plasmid. 
These cells were grown in DMEM (with 10%FCS and 1%PS), DMEM (with 
10%FCS and 1%PS)+HAT and DMEM (with 10%FCS and 1%PS)+6-TG.  
B. Western-blot was performed to show the expression of hH1-CubRGpt2 
using antibody against the HA tag which had been incorporated into the Cub 
part of the reporter construct. 
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Figure 3.2. hH1 interacts with core histones hH3 and hH4 and not hH2A 
and hH2B. 
Phenotype of HT1080HPRT- cells seen in DMEM+FCS, DMEM+FCS+HAT and 
DMEM+HAT+6-TG after transfection with hH1-CubRGpt2 and pcDNA3.1 (Neomycin Resistance Marker) expressing hH2A, hH2B, hH3 and hH4 cloned 




















The cells were subsequently transfected independently with 
pcDNA3.1/Neomycin containing Nub and Nub fused to each of the core human 
histone proteins hH2A, hH2B, hH3, and hH4. The protein-protein interaction 
between hH1 and any of the four core histone proteins would bring Nub and Cub 
in close proximity, resulting in the formation of a ubiquitin-like moiety and the 
cleavage of hH1-CubRGpt2 releasing the RGpt2 part of the fusion. The enzymes 
of the “N-end rule” pathway degrade RGpt2 so rapidly that the cells become 
phenotypically HPRT deficient, resulting in HAT sensitivity and 6-TG resistance. 
Figure 3.2 shows that cells expressing hH1-CubRGpt2 together with Nub-hH2A 
and Nub-hH2B remained HAT resistant and 6-TG sensitive. However, co-
expression of Nub-hH3 or Nub-hH4 changed the growth phenotype of hH1-
CubRGpt2 expressing cells to HAT sensitivity and 6-TG resistance. We conclude 
from these experiments that the human linker-histone hH1 contacts core-
histone proteins hH3 and hH4, but not the core histone proteins hH2A and 
hH2B, directly inside human cells.  
To further verify the interactions of the histone protein hH3 and hH4 with the 
linker histone hH1, HT1080HPRT- cells lines stably expressing the Cub  and Nub 
fusions were lysed and the protein extracts were run on 12% SDS PAGE gel. 
Immunoblotting was performed to detect the Cub and Nub fusions with an antibody 
against the HA tag which had been incorporated into these halves. Figure 3.3 
shows that cells expressing hH1-CubRGpt2 and Nub fused to either hH2A or 
hH2B displayed both the Cub and Nub bands indicating that no in vivo interactions 
between these two core histones and the linker histones had taken place. 
However, when Nub-hH3 and Nub-hH4 were co-expressed with hH1-CubRGpt2, 
the hH1-CubRGpt2 band was reduced, indicating interaction between hH1 and 
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hH3 as well as between hH1 and hH4 followed by the cleavage of the CubRGpt2 
fusion by the cellular proteasomal machinery.  
Verification of interactions between core histones and linker histone by co-
immunoprecipitation- We performed co-immunoprecipitation with HEK293 cells 
in order to confirm the protein-protein interactions between hH1 and hH3 and 
hH1 and hH4 (Figure 3.4). hH1 was tagged with myc and the core histones 
hH2A, hH2B, hH3 and hH4 were tagged with HA. The immunoprecipitation was 
performed with an anti-HA antibody coupled to sepharose beads. The pelleted 
proteins were separated on two 12% SDS PAGE gels. The expression of both 
myc-tagged hH1 and HA-tagged core histones in HEK293 cell extracts was 
verified by Western blots shown in Figures 3.4, A and B. In Figure 3.4 C, 
binding of HA tagged core histones to the sepharose beads was confirmed.  
Figure 3.4 D shows that myc-hH1 was co-precipitated from cell extracts 
containing HA-tag fused to any of the four core histones hH2A, hH2B, hH3 or 
hH4 (lanes 3-6), but not from cell extracts lacking HA-tagged histones (lane 2). 
The core histones form the octamer complex within the nucleosome. We 
presume that for hH2A and hH2B, hH1 was co-precipitated indirectly by 
interacting with the hH3 and hH4 component of the nucleosome.  
Note that a 10.1kD C-terminally truncated myc-hH1 fragment did not interact 
with the any of the core histone proteins in the nucleosome. We conclude that 
the C-terminus of hH1 is essential for binding to the nucleosome, a result 
consistent with a previous finding reporting that the C-terminal domain is 





Figure 3.3. Western-blot analysis showing in vivo interaction: 
Untransfected HT1080HPRT- HPRT- cell lysate (Lane 1), HT1080HPRT- cells 
expressing hH1-CubRGpt2 and Nub-hH2A (Lane 2), hH1-CubRGpt2 and Nub-hH2B (Lane 3), hH1-CubRGpt2 and Nub-hH3 (Lane 4), hH1-CubRGpt2 and Nub-hH4 (Lane 5).Note that the band for hH1-CubRGpt2 is diminished in lane 4 and 





































Figure 3.4. Co-Immunoprecipitation showing binding of linker histone hH1 
to core histones in vitro.  
HEK293 cell extracts were transfected with pCMV-myc-hH1 alone or pCMV-
myc-hH1 with pAAV-Nub-hH2A, pAAV-Nub-hH2B, pAAV-Nub-hH3 and pAAV-Nub-
hH4. Standard Molecular Weight Markers (SM) are shown on the left-hand side 
of each figure.  
A. Expression of Nub-hH2A (lane 1), Nub-hH2B (lane 2), Nub-hH3 (lane 3) and 
Nub-hH4 (lane 4) in HEK293 cell extracts was verified by Western-blot 
using anti-HA antibody. 
B. Expression of myc-hH1 (17.9kD) was verified by Western-blot using anti-
myc antibody, lane 1 consists of HEK293 cell extracts transfected with 
pCMV-myc-hH1 alone. Lanes 2-5 consist of HEK293 cell extracts co-
expressing pCMV-myc-hH1 along with Nub fused to hH2A (lane 2), hH2B (lane 3), hH3 (lane 4) and hH4  (lane 5). The lower represents a 
truncated form of myc-hH1 with a molecular weight of 10.1kD. 
C. Co-immunoprecipitation was performed using anti-HA tagged sepharose 
beads. Nub fused to core histones hH2A (lane 1), hH2B (lane 2), hH3 (lane 3) and hH4 (lane 4) are detected by Western-blot using anti-HA 
antibody. The heavy chains (HC) and light chains  (LC) of anti-HA are 
released from the beads after boiling the sepharose beads in loading 
buffer which contains a reducing agent.   
D. Binding of myc-hH1 to the beads was observed by using anti-myc 
antibody for extracts containing Nub-hH2A, Nub-hH2B, Nub-hH3 and Nub-
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hH4 (lanes 3, 4, 5 and 6, respectively). Lane 1 contains Anti-HA tagged 
sepharose beads incubated with HEK293 cell extracts alone. Lane 2 
contains beads with myc-hH1 only. Lane 7 contains whole 2% input of 
HEK293 cell extract expressing myc-hH1. A truncated product of 10.1kD 
was also observed. The heavy chains (HC) and light chains (LC) are 
















































Molecular modeling shows contact of linker histone H1 with core histones H3 
and H4 at the dyad axis of symmetry- Two models regarding binding of H1 to 
the nucleosome have been proposed (Figure 3.5). They differ with respect to 
the orientation of the linker histone and the nucleosome. The “off-dyad-model” 
proposed by Pruss and Wolffe (Pruss and Wolffe,1993) states that the globular 
domain of the linker histone binds nucleosomal DNA 60 to 70 bp from the dyad-
axis while the second DNA site does not contact the DNA. In the second model, 
(Zhou et al., 1998), the globular domain binds to the DNA at the dyad-axis 
through one site while the second site binds either the entering or exiting 
nucleosomal DNA. Molecular modeling was performed with the nucleosome 
(Luger et al., 1997) and the globular domain of the chicken linker histone (Cerf 
et al., 1993) using the PyMOL molecular modeling software. DNA (blue and 
cyan) is shown wrapped around the histone octamer complex, consisting of 
core histones H2A (white), H2B (wheat), H3 (green) and H4 (magenta). The 
DNA-contacting residues of H1 lie on opposite ends of the winged helix DNA 
binding domain (dark blue). Amino acid residues 67, 69, 73 and 85 (red) form a 
basic cluster and constitute the first DNA binding site, while the amino acids at 
positions 40 and 42 (orange) form the second DNA binding site on the opposite 
end. These residues have been shown to contact nucleosomal DNA by photo-
cross-linking and site-directed mutagenesis experiments (Bharath et al., 2003). 
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 C.             
  D.  
Figure 3.5 Molecular modeling confirms contact of linker histone at the 









A. Molecular modeling was performed with the nucleosome and the 
globular domain of the chicken linker histone using the PyMOL 
molecular modeling software. DNA (blue and cyan) is shown 
wrapped around the histone octamer with H2A (white), H2B 
(wheat),H3 (green), H4 (magenta).The winged helix DNA binding 
domain of histone H1(blue) is seen with the DNA contacting 
residues (red and orange) lying on opposite ends of the molecule.  
Residues 67, 69, 73 and 85 form a basic cluster on one end while 
residues 40 and 42 (orange) form the second DNA binding site on 
the opposite end.  
B.  (a)Off-Dyad model proposed by Pruss and Wolffe, 1993, where 
the globular domain  binds nucleosomal DNA 60 to 70bp from the 
dyad axis while the second DNA site does not contact the DNA. In 
the second model by (b) Zhou et al., 1998, the globular domain 
binds to the DNA at the dyad axis through one site while the 
second site binds either the entering or exiting nucleosomal DNA. 
C. and D.  Linker histone H1 contacting nucleosomal DNA at the 
dyad axis as well as the core histones H3 and H4 in two possible 
orientations.  



















This modeling has been performed according to the protein-protein interactions 
observed in our previous experiments between the linker histone H1 and H3 
and H1 and H4. We can see that the alignment of H1 over the H3-H4 
nucleosomal surface is consistent with the model proposed by Zhou et al. in 
1998, according to which H1 binds at the dyad-axis of symmetry.  
These results help to further validate our results in the context of the core 
nucleosomal particle.  
 
3.3   DISCUSSION 
 
Arrays of nucleosomes formed by histone octamers (H2A, H2B, H3 and H4) are 
compacted by the fifth type of histone H1 that binds to DNA as it enters and 
exits the nucleosome. Our results show that the human linker histone hH1 also 
contacts histones hH3 and hH4, which are present in the core nucleosome 
octamer complex. This has been demonstrated with the help of the split-
ubiquitin system inside human HT1080HPRT- cells. The split-ubiquitin system is 
a two-fragment complementation assay where interaction of two proteins 
results in the degradation of an RGpt2 reporter fused to Cub. Expression of Nub -
hH3 and Nub-hH4, but not hH2A and hH2B, with hH1-CubRGpt2 leads to a switch 
in the HAT resistance and 6-TG sensitivity to HAT sensitivity and 6-TG 
resistance phenotype. Furthermore, Western-blot analysis demonstrated the 
degradation of hH1-CubRGpt2 upon co-expression of Nub-hH3 and Nub-hH4. hH1-
CubRGpt2 remained intact in the presence of Nub-hH2A and Nub-hH2B. Both 
results indicated a specific interaction of hH1 with hH3 and hH4 but not with 
hH2A and hH2B. 
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Co-immunoprecipitation showed that hH1 was brought down by all the HA-
tagged core histones. This observation can be explained by the fact that the 
core histones aggregate into the octamer complex inside the cells. hH1 was 
pulled down with HA-tagged hH2A and hH2B by indirect interaction, as hH2A  
and hH2B bind  hH3 and hH4, which in turn contact hH1.  
Along with myc-hH1 a C-terminally truncated product of around 10kD was 
detected in the all the HEK293 cell extracts. However this fragment did not bind 
to any of the core histones. This result is consistent with a previous study which 
has shown that the C-terminal domain of H1 binds with high affinity to 
chromatin in living cells. Modeling studies have revealed that the SPKK-motifs 
found on the C-terminus are sites of DNA binding and compaction (Bharath et 
al., 2003). Our results highlight the role of the core histones, specifically hH3 
and hH4, in recruitment of the linker histone hH1 to the nucleosome via its C-
terminal domain.  
The split-ubiquitin assay relies on close proximity of the two fusions excluding 
indirect interactions. Nub-hH2A and Nub-hH2B did not result in a positive signal 
upon co-expression with hH1-CubRGpt2 as the distance between the two halves 
of the ubiquitin was too large. Only the co-expression of Nub-hH3 and Nub-hH4 
with hH1-CubRGpt2 resulted in the cleavage of the CubRGpt2 fusion as only a 
direct interaction brings Nub and Cub close enough to reconstitute a ubiquitin-like 
moiety.  
We were not able to pull down HA-tagged hH1 expressed in HEK293 cells with 
GST-histone fusions expressed in E. coli. There are two possible explanations 
for these observations. (1) The histones have to be appropriately modified for 
these interactions to occur in vivo. E. coli is a prokaryote and is therefore 
deficient in histone proteins and the enzymes essential for their 
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posttranslational modifications. (2) The interactions between the linker histone 
hH1 and core histones might be dependent on the presence of nucleosomal 
DNA. Nucleosomes are not present all prokaryotes including E. coli. 
The split-ubiquitin system seems to the most appropriate platform for testing 
the interactions between H1 and core histones as it is an in vivo interaction 
assay. It is known that histone proteins are subjected to a variety of 
posttranslational modifications inside the cells. Posttranslational modifications 
help to determine not only unique structural conformations but also make the 
surfaces of histone proteins favorable or unfavorable for binding of specific 
factors. For example, bromodomain proteins bind specifically to acetylated 
histones H3 and H4, a signal for transcriptional activation. HP1 and other 
silencing proteins recognize histone H3 K9 methylation to induce silencing. 
Other modifications in the core nucleosome include methylation of R53 on 
histone H3 and R92 on H4 whose functions remain unknown (Cosgrove et al., 
2004).   
Previously it has been shown that the core nucleosomal surface is crucial for 
transcriptional silencing in S.cerevisiae (Park et al., 2002). Certain missense 
alleles of histones H3 and H4 were found to have phenotypes similar to those 
of sir2 mutants, which are completely defective in silencing of rDNA. These lrs 
(loss of rDNA silencing) mutants also affect silencing of telomeres and the 
silent mating loci in yeast.  Hence the core nucleosomal surface formed by the 
H3 and H4 might also be involved in recruiting silencing complexes like the 
PcG (Polycomb group), HP1 and the linker histone H1 in mammalian cells. 
Binding of the linker histone H1 to H3 and H4 would perhaps mediate unique 
transcriptional effects which are yet to be investigated. Also it is not known 
which amino acid residues are involved in this interaction. Determination of 
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interacting residues and specific posttranslational modifications of histones 
which regulate binding of the linker histone to the core histones H3 and H4 
might elucidate the mechanisms involved in its recruitment to the nucleosomal 
core.  
Hho1p is the homolog of the linker histone in S.cerevisiae. Disruption of HHO1 
has no detectable defects in chromatin structure, transcriptional silencing at 
telomeres or mating type loci relative to wild type strains (Patterton et al., 
1998). However, Hho1p plays a significant role in controlling homologous 
recombination activity during DNA damage response (Downs et al., 2003).  
 The function of mammalian linker histones is quite in contrast to their yeast 
homolog Hho1p. There are five known isoforms of Histone H1 in mammals 
(H1.1, H1.2, H1.3, H1.4 and H1.5) as well as a lesser studied H1 isoform H1.X.  
Simultaneous inactivation of these multiple H1 subtype genes caused 
embryonic lethality in mice (Wang et al., 1997). These subtypes have been 
shown to exhibit tissue specific and cell-cycle dependent expression patterns 
indicating that they are indeed important for the regulation of gene expression 
(Lennox et al., 1983 and Alami et al., 2003). Additionally, the linker histone  
specifically cooperates with the transcription factor Msx1, containing a DNA 
binding domain,  and inhibits the expression MyoD gene (Lee et al., 2004)  
which encodes a master regulatory switch directing differentiation of progenitor 
cells into muscle in  Xenopus laevis. Linker histone variants specifically 
regulate chromatin dynamics during embryonic development in Xenopus 
indicating unique functions of these variants (Saeki et al., 2005).  
It is possible that these variants might show differences in their recruitment to 






We have demonstrated that the linker histone hH1 interacts with core histone 
proteins hH3 and hH4 using the split-ubiquitin system inside human cells. 
Western-blot analysis and co-immunoprecipitation further helped to validate 
these interactions in the context of the nucleosome. Furthermore, alignment of 
the linker histone on the nucleosomal dyad-axis of symmetry by molecular 
modeling with PyMOL software confirms these findings whereby the linker 
histone is shown to contact H3 and H4. These results support the model 
proposed previously by Zhou et al.  in 1998, whereby the linker histone binds 
the nucleosome on the dyad-axis of symmetry.   
 
3.5. FUTURE WORK 
 
It would be useful to map the exact interaction domains contacting each other, 
both on the linker histone hH1 and the core histone proteins hH3 and hH4. This 
could be done by deletion analysis and cloning of specific domains of the 
proteins into pcDNA3.1 expression vectors fused to either Cub-RGpt2 or Nub 
followed by the testing of phenotype of HT1080HPRT- cells as mentioned in the 
Materials and Methods section. Another facet to study would be the specific 
posttranslational modifications that might be involved in these interactions. H1 
has been shown to possess numerous phosphorylation states (Cosgrove et al., 
2004), which might regulate its binding to the chromatin template. Moreover, 
modifications of the core nucleosomal surface like acetylation/deacetylation, 
methylation, phosphorylation and ubiquitination might either attract or repel the 
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linker histone according to the transcriptional status of the genes during 
development and differentiation. Using antibodies against various histone 
modifications after co-immunoprecipitation of the linker histone with differently 
tagged core histones H3 and H4 could determine the binding preference of the 
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The experiments that were performed in the previous chapter demonstrated 
the ability of the split-ubiquitin system to detect interactions between the 
linker histone hH1 and the core histone proteins hH3 and hH4 directly inside 
human cells.  
This encouraged us to develop this system for the purpose of screening a 
human cDNA library fused to Nub against the linker histone hH1 as a bait 
protein fused to CubRGpt2.  The linker histone plays an important role in 
controlling chromatin dynamics as described in the previous chapter. The 
mechanisms by which it is specifically recruited to the silenced regions of 
the chromatin are still not properly understood. Screening of interacting 
partners of the linker histone H1 might yield interesting insights regarding its 
recruitment, regulation and turn over during chromatin condensation and de-
condensation occurring in the various stages of development and 
differentiation.  
For the purpose of developing a high-throughput screening protocol based 
on the split-ubiquitin system, the AAV Helper-Free System (Stratagene) was 
used for delivery and expression of a potential human cDNA library. This 
system utilizes Adeno-associated viruses for stable expression of genes 
inside human cells. 
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The human parvovirus Adeno-associated virus (AAV) grows in mammalian 
cells in the presence of helper functions provided by adenovirus or herpes 
(Carter and Laughlin, 1984).  AAV is limited for replication only by the host 
range of the helper and will grow in a variety of cell lines if the appropriate 
helper function is provided. In the absence of helper function, the AAV 
genome frequently integrates into the host cell chromosome with no 
apparent effect on cell growth or morphology (Cheung et al., 1980). 
Subsequent addition of helper virus allows excision of these integrated AAV 
genomes and replication to produce AAV particles (Hoggan et al., 1972). 
Thus, AAV has been developed as a vector for the introduction of genes 
into human cells in either a chromosomal or an episomal state.  
 Other viral delivery systems include retroviruses, adenoviruses and herpes 
simplex based viruses. Retroviral systems are quite simple and 
straightforward to manipulate (Lois et al., 2001). They integrate into the 
genomes of mostly dividing cells. However, some retroviruses can infect 
non-dividing cells as well. Many popular gene delivery vectors are derived 
from classical retroviruses such as the Moloney murine leukemia virus 
(MoMLV). The genomes are typically 7-12kB in size and code for three 
structural genes gag, pol, and env. A second category of retroviruses called 
complex retroviruses, including HIV and other lentiviruses carry additional 
genes for a number of regulatory proteins (Naldini et al., 1996). The 
retroviral genome also contains a number of cis-acting elements called the 
LTRs or the long terminal repeats found at the ends of integrated provirus. 
The structural genes are mostly derived from the packaging cell lines in 
trans. This allows greater amount of space for the genes of interest to be 
transferred and also makes these viruses replication-defective.  
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Adenoviruses have a high cloning capacity to accommodate most cDNAs. 
They can infect both replicating and quiescent cells and can be grown to 
high titers allowing them to be easily purified. They are also replication 
deficient and can deliver DNA with high efficiency both in vitro and in vivo. 
The first generation vectors have a number of drawbacks including lack of 
integration into the host genome and limited duration of expression linked to 
immunogenicity (Bramson et al., 1995). Herpes simplex based vectors have 
mostly all the features of the viral vectors mentioned above, with the 
exceptional ability to carry very large amounts of DNA. 
Recombinant Adeno-associated viruses (AAVs) have 96% of their genome 
removed which is extremely debilitating for this virus. This is one reason 
why AAV has the highest bio-safety rating among viral vectors. (Samulski et 
al., 1989). In the absence of helper functions AAV, readily establishes 
latency. Recombinant AAV transduces both mitotic and post mitotic cells, 
making it an ideal system for gene transfer.  
As mentioned above, Adeno-associated viruses (AAVs) are replication 
deficient parvoviruses, which have traditionally required co-infection with a 
helper adenovirus or herpes virus for productive infection. Stratagene’s AAV 
Helper-Free System allows the production of infectious recombinant human 
Adeno-associated virus-2 (AAV-2) virions without the use of a helper virus 
(AAV Helper-Free System Instruction Manual). Most of the adenovirus gene 
products required for the production of infective AAV particles are supplied 
on the plasmid pHelper (i.e. E2A, E4, and VA RNA genes) that is co-
transfected into cells with AAV-2 vector DNA (Matsushita et al., 1998). The 
remaining adenoviral gene products are provided by the cell line AAV-293 
host cells, which stably express the adenovirus E1 gene (Graham et al., 
 
106
1977). By eliminating the requirement for a live helper virus, the AAV 
Helper-Free System provides a safer alternative to retroviral and adenoviral 
gene delivery systems.  
The wild-type AAV-2 genome consists of the viral rep and cap genes 
(encoding replication and capsid genes respectively), flanked by inverted 
terminal repeats (ITRs) that contain all the cis-acting elements necessary for 
replication and packaging.  In the AAV-Helper Free System, the rep and cap 
genes have been removed from the viral vector that contains AAV-2 ITRs 
and are supplied in trans on the plasmid pAAV-RC. The removal of the AAV 
rep and cap genes allows for insertion of a gene of interest in the viral 
genome. Inserts up to 1.7kb can be incorporated into pAAV-IRES-hrGFP 
plasmid. 
The AAV Helper Free System can produce recombinant viral titers of • 107 
viral particles per ml of primary viral stock. It is extremely valuable for long-
term gene expression due to the ability to integrate into the host genome at 
a rate of 5-10%. Hence in a population of rapidly dividing cells stably-
expressing cells can be selected. Human proteins hence expressed are 
abundant and subjected to correct folding and posttranslational 
modifications. This feature makes it suitable for the selection of clones in 6-
TG containing medium. 
For the purpose of constructing a cDNA library, Nub has been cloned into the 
pAAV-IRES-hrGFP vector in three reading frames as described in the 
Materials and Methods section. This vector contains the AAV-2 inverted 
terminal repeats (ITRs), which direct viral replication and packaging. The 
pAAV-IRES-hrGFP vector also contains a di-cistronic expression cassette in 
which the humanized recombinant green fluorescent protein (hrGFP) from a 
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novel marine organism is expressed as a second open reading frame that is 
translated from the encephalomyocarditis virus (ECMV) internal ribosome 
entry site (IRES). hrGFP fluorescence can be used to measure the titer of 
the recombinant virus stock directly. Since the Nub fusion and hrGFP are 
translated from the same transcript, hrGFP expression may be used to 
ascertain the infection efficiency for the desired target cell type and also 
serves as a useful expression marker for the inserted gene of interest.  
AAV yield can be improved approximately 10-fold when cap gene 
expression is increased, implying that the level of capsid protein is one 
limiting factor for the production of AAV particles (Vincent et al., 1997). Viral 
stock concentration and purification can be performed by CsCl gradient 
centrifugation, iodixanol/heparin or HPLC based purification. An easy-to-do 
single-step column purification (SSCP) method based on the affinity of AAV-
2 to heparin has been devised to obtain high titers and infectivity (Auricchio 
et al., 2001). An alternative procedure is the two-step ion-exchange 
chromatography process for the purification of AAV-2. This relies on two 
ion-exchange resins: the first one being SP Sepharose HP, which is a cation 
exchanger resin and the second one, Source 15Q, an anion exchange resin 
(Brument et al., 2002).  
In order to test this system for screening purposes, human histones hH3 
and hH4 (previously identified to interact with the linker-histone hH1) were 
cloned in frame with Nub. Human Prothymosin was used as a positive control 
to test this system as it has been shown previously to interact with the linker 
histone H1 in vitro (Karetsou et al., 1998). The recombinant expression 
plasmid was then co-transfected into the AAV-293 cells with pHelper 
(carrying AAV-2 replication and capsid genes) and pAAV-RC (carrying AAV-
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2 replication and capsid genes), which together supplied all of the trans-
acting factors required for synthesis of these AAV particles. 
The second step involved the infection of HT1080HPRT- cells expressing 
the bait protein with these viral stocks. The viral plasmid DNA carrying the 
Nub or the Nub-fusion protein integrated with high efficiency into the host 
genome. Cells showing GFP expression were purified by FACS 
(Fluorescence Activated Cell Sorting) analysis and ultimately selected for 
protein-protein interactions in medium containing 6-TG and zeocin.  
We used Fluorescence Activated Cell Sorting to successfully isolate 
infected HT1080HPRT- cells. Flow cytometers use a principle involving 
electrostatic deflection of charged droplets similar to that used in ink-jet 
printers. All streams are unstable with respect to time and eventually break 
up into droplets. It is possible to stabilize this break-off point by applying a 
stationary wave of vibration of known frequency and amplitude to the 
stream. The analysis of fluorescence of selected populations is measured 
first by resolving cell populations by forward and 90º angle light scatter. The 
auto-fluorescence of uninfected cells, which do not show any expression of 
hrGFP is also measured and subtracted from the final analysis of cells. This 
subtraction is achieved with the help of the computer analysis software.  





Monitoring Viral Production-AAV-293 cells growing in 6-well plates were co-
transfected with pAAV-IRES-Nub-hH3/hH4/hProthymosin-IRES-hrGFP 
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plasmids along with pHelper and pAAV-RC. For viral titer determination, 
pAAV-LacZ was also co-transfected with pHelper and pAAV-RC in separate 
wells. Untransfected AAV-293 cells were taken as a negative control. After 
two days, a distinct color change in the medium from red to orange was 
observed. There was no color change observed for untransfected cells (See 
Figure 4.1.). The cells rounded up and detached from the plate. Some cells 
were seen floating in the medium.  Moreover hrGFP expression was also 
observed in the cells when visualized under Fluorescence Microscope. 
Viruses were recovered by a freeze-thaw lysis procedure as described in 
the Materials and Methods Chapter.  
Infection of HT1080HPRT- cells with AAV-2- HT1080HPRT- cells expressing 
hH1-CubRgpt2 were infected with viral stocks and incubated at 37ºC, 5% 
CO2 for a period of three to four days. hrGFP expression was visualized in 
roughly 7% of the cell population using an Inverted Fluorescence 
Microscope.  
Viral Stocks for pAAV-LacZ were also used to infect HT1080HPRT- cells to 
determine viral titers according to the formula mentioned in Materials and 
Methods. The viral titers were calculated as described in Materials and 
Methods (See Table 4.1.). Around 107 infectious units (IFU) per ml of viral 
stock were recovered.  
Fluorescence Activated Cell Sorting- Cells expressing GFP di-cistronically 
with Nub alone or Nub fused to human hH3/hH4/hProthymosin were isolated 
by Fluorescence Activated Cell Sorting (FACS) Analysis. In brief, cells were 
first collected in sterile tubes. Uninfected cells were taken as negative 
control, and the auto-fluorescence exhibited by the cells was subtracted 
from of analysis of cells expressing GFP. Afterwards the GFP expressing 
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cells were appropriately gated to isolate them. Cells were sorted into 24-well 
plates at a density of 50 cells per well. After allowing a recovery period of 
two days, the cells were trypsinized and transferred into medium containing 
6-TG and zeocin to select for positive protein-protein interactions. Table 4.2 
highlights the recovery rate of cells after FACS in these 24-well plates. 
Selection in 6-TG for Protein-Protein Interactions-Cells from each well were 






Figure 4.1. Schematic representation of protocol for screening of protein-protein 
interactions inside human HT1080HPRT- cells expressing hH1-C
ubRGpt2. 
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interactions in vivo. Genomic DNA was extracted from the cell cultures by 
phenol-chloroform extraction (See Figure 4.3). 
The integrated viral DNA was amplified specifically by using primers hybridizing 
within the ITR cassette.  As a control, PCR was also carried out to amplify 
histone hH3 as an indication of the quality and intactness of the genomic DNA 
isolated (Figure 4.4). For the positive control, a PCR Product of 312 bp was 
detected in lanes (1, 3, 5, 7, 9, 11, 13 and 15).   
Histone hH4 was amplified from the genomic DNA in lanes 2 and 4 (533 base 
pairs), histone hH3 in lanes 6 and 8 (632 base pairs) and hProthymosin in 
lanes 10 and 12 (544 base pairs). Nub (expected size 372 base pairs) was not 
amplified from any of the genomic DNA isolated. This indicated that that there 
were no stable integrations of the viral DNA containing Nub (See Figure 4.4.).   
As can be seen from Table 4.1., the flow sorting procedure was highly efficient 
in enriching cells expressing Nub fusion proteins di-cistronically with GFP. 
Moreover all the candidates that were tested for stable integration of the viral 
plasmid DNA into the genome using PCR showed positive amplifications. For 
pAAV-Nub-IRES-GFP, only three colonies showed growth in 6-TG and zeocin. 
To rule out the possibility of any interaction of Nub with the bait protein, PCR 
was carried out to detect integrations that might have taken place into the 
genomic DNA of HT1080HPRT- cells. However, no integrants were detected, 
indicating that the colonies which grew in 6-TG and zeocin actually arose 
because of antibiotic resistance developing in these rapidly dividing cells due to 
a certain low level spontaneous mutations. 
Sequencing PCR Products- The PCR products were purified and sequenced 
using the Nub129 primer. Sequences of human histones hH3, hH4 and 
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hProthymosin were retrieved by performing a Nucleotide-nucleotide BLAST 




AAV-2 or Adeno-associated viruses are replication deficient viruses which have 
the highest bio safety ratings among all other viruses currently being used for 
gene delivery and expression in human cell lines. Moreover these viruses have 
a high rate of integration into the human genome, specifically into Chromosome 
17 (Waltz and Schlehofer, 1992). These reasons justify the utilization of the 
AAV-Helper-Free-System for screening of protein-protein interactions inside 
human HT1080HPRT- cells. As part of the split-ubiquitin system, hH1-CubRgpt2 
has been employed as a bait protein. Using this novel protocol for screening a 
potential human cDNA library (Figure 4.1.), potential interacting partners fused 
to Nub can be isolated by selection of HT1080HPRT
-
 cells expressing hH1-
CubRGpt2 in a medium containing 6-TG and zeocin. 
The pAAV-IRES-hrGFP plasmid contains a di-cistronically expressed hrGFP 
protein which is a useful marker for selection of positively infected 
HT1080HPRT- cells using Fluorescence Activated Cell Sorting Procedure. 
This process is highly efficient in enriching cells expressing the Nub- fusion 
proteins along with hrGFP. These cells are then subjected to the second 
selection step involving 6-TG and zeocin. Isolation of genomic DNA and PCR 
amplification of the integrated DNA further eliminates any false positives 
obtained in 6-TG and zeocin. 
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AAV-293 cells  (Uninfected)                   
AAV-293 cells (with cytopathic effects     
AAV-293 cells (hrGFP expression)          
 
Figure 4.2. AAV-293 cells. 
Uninfected AAV-293 cells (top); AAV-293 cells showing cytopathic effects 
indicating AAV-2 production after transfection with pAAV-Nub-IRES-hrGFP 
plasmid, pAAV-RC and pHelper plasmids (middle); AAV-293 cells showing 
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   Figure 4.3. Isolation of genomic DNA from clones  
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Figure 4.4. PCR Amplification to Detect Viral Plasmid DNA Inserted into 
Genomic DNA.  
Two independent colonies were picked following selection in 6-TG after 
infecting hH1-CubRgpt2 expressing HT1080HPRT
-
 cells with pAAV-Nub-hH4-
IRES-hrGFP (lanes 1-4), pAAV-Nub-hH3-hrGFP (lanes 5-8), pAAV-Nub-
hProthymosin-hrGFP (lanes 9-12), and pAAV-Nub-hrGFP (lanes 13-16) carrying 
AAV particles. PCR was performed using either primers for the gene encoding 
human histone hH3 as a positive control (Size 411 base pairs) for isolation of 
intact human genomic DNA from the HT1080HPRT- cell line clones infected as 
mentioned above (Lanes 1, 3, 5, 7, 11, 15) or using primers lying in the Beta-
Globin intron and IRES sequences to amplify the viral plasmid DNA integrated 
into the genome. Histone hH4 was amplified from the genomic DNA in lanes 2 
and 4 (533 base pairs), histone hH3 in lanes 6 and 8 (632 base pairs) and 
hProthymosin in lanes 10 and 12 (544 base pairs). Nub (expected size 372 base 
pairs) was not amplified from any of the genomic DNA isolated indicating that 






















Table 4.1. Viral Titer Estimation after Infection of HT1080HPRT- Cells with 
pAAV-LacZ stocks 
 
Dilution Number of Infected Cells per Field IFU/ml 
1x 10-2  TNTC~ - 
2x 10-3 68 1.22x 107 
4x 10-4 56 5.01x 107 





















pAAV-Nub-IRES-hrGFP 22/24 3 0 
pAAV-Nub-Hh3-IRES-hrGFP 19/24 19 2/3 
pAAV-Nub-hH4-IRES-hrGFP 21/24 21 2/2 
pAAV-Nub-hProthymosin-
IRES-hrGFP 
















6-thioguanine or 6-TG is a cytotoxic purine and spontaneous resistance to this 
compound has been shown to arise on a number of occasions in various cell 
lines.  
 This resistance is mediated by loss or reduction in hypoxanthine 
phosphoribosyltransferase (HPRT) activity. This phenomenon has been 
recorded in human lymphoid cells (Duncan, 1977) and in Chinese Hamster 
Ovary (CHO) cells (Manjanatha et al., 1994). Mutants isolated in CHO cells 
were shown to contain certain exon-deletions, point deletions, missense or 
nonsense mutations in the HPRT gene.  Hence it was not surprising that a few 
false positives were obtained for cells growing in medium containing this 
selecting agent. 
Posttranslational modifications of human proteins play an important role in 
governing their folding and hence determine the possible interacting partners 
for a given protein expressed inside human cells. This fact has been shown to 
be especially relevant for histone proteins whose modification status can lead 
to the recruitment of different chromatin binding proteins. Hence making use of 
the split-ubiquitin system inside human cells for screening of interacting 
partners for human proteins, presents itself as a powerful tool for identifying 
relationships between proteins involved in regulating chromatin architecture like 
the histones.   
The efficiency of isolation of interacting partners depends on the successful 
execution of Fluorescence Activated Cell Sorting (FACS) procedure to purify 
positively transduced cells. The population of cells expressing GFP currently is 
not very high (about 6 to 7%). The percentage of infected cells could further be 
increased by devising certain viral purification procedures to concentrate viral 





Utilizing Adeno-Associated Viruses to deliver Nub fusions into HT1080HPRT
-
 
cells expressing hH1-CubRGpt2 as a bait protein is an efficient and a reliable 
method for determining novel protein-protein interactions for human 
proteins. This protocol has a low rate of obtaining false positives which can 
nevertheless be easily identified by PCR amplification of integrated viral 
DNA. This AAV based method can hence be used to deliver a human cDNA 
library into cells and colonies obtained in 6-TG would reveal interacting 
partners for any chosen bait protein. Subsequent isolation of genomic DNA, 
PCR and sequencing would yield the identity of interacting partners. 
 
4.5. FUTURE WORK 
 
This protocol is ideal for screening a cDNA library constructed from RNA 
isolated from any of the human cell-lines in common use. A cDNA library 
could be cloned in pAAV-Nub-IRES-hrGFP vector containing Nub in three 
reading frames. One very exciting option would be to construct cDNA 
libraries based on RNA isolated from embryonic stem cell lines. Screening 
of interacting partners using these cDNA libraries could yield interesting 
insights regarding mechanisms that govern changes in chromatin 
accessibility and dynamics during various stages of development and 
differentiation. Using cancer cell line-based cDNA libraries could also help 
identify valuable interactions for key regulatory proteins involved in cancer 
signaling and manifestation of tumors. To further validate any newly 
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discovered interactions, alternative in vitro procedures like GST pull-down 
and co-immunoprecipitation would have to be carried out.  
The transcriptional significance of interacting partners could be studied by 
various methods like siRNA induced silencing of these novel candidates. 
Specific activation and repression mechanisms of identified transcriptional 
factors could be validated by monitoring reporter gene expression. Possible 
effects on changes in gene expression could also be investigated by Real-
Time PCR of target genes. The bait protein in our experiments is the human 
linker histone hH1, which plays an important role in governing chromatin 
accessibility. The effects on chromatin states for any of the novel interacting 
candidates, could be studied by micrococcal nuclease digestion of the 
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